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Leishmaniasis, as defined by the Center for Disease Control and Prevention, is a 
neglected tropical disease with 1.6 million new cases reported each year. However, there is yet to 
be safe, effective, and affordable treatments provided to those affected by this disease 
(Leishmaniasis, 2016). Still underappreciated as potential pharmaceutical targets, especially for 
cutaneous leishmaniasis infections, are the two isozymes of secreted acid phosphatase (SAP), 
secreted acid phosphatase 1 (SAP1) and secreted acid phosphatase 2 (SAP2).  These enzymes are 
involved in the survival of the parasite in the sand fly vector, and the prevention of host 
macrophages from forming parasitophorous vacuole and hydrogen peroxide (Fernandez Soares, 
Saraiva, Meyer-Fernandez, Souto-Padron, 2013;M. Baghaei and M. BAGHAEI, 2003). Thus, the 
kinetic behavior of these SAPs is of interest. Vanadium (V5+), specifically the monomeric 
oxyanion orthovanadate (VO43-), is reported to be a competitive inhibitor of phosphatases 
(VanEtten, Waymack, Rehkop, 1974; Abbott, Jones, Weinman, Backhoff, McLafferty, 
Knowles,1979; Knowles, 1980; Gressor, Tracey, Stankiewwicz, 1987; Gordon, 1991; Li, Ding, 
Baruah, Crans, Wang, 2008). Orthovanadate serves as a known competitive inhibitor for the 
enzyme inhibition experiments done in the research presented here. The application of electric or 
electromagnetic fields as a medicinal therapeutic is not new (Holden, 2017). The utility of 
applying electric fields for the treatment of leishmaniasis is under studied (Hejazi, Eslami, 
Dalimi, 1972), and the application of electric fields to Leishmania secreted acid phosphatases has 
not yet been reported. The results of such studies using L. tarentolae as a model system, with and 
without the addition of orthovanadate, are reported here. Furthermore, the effect specific electric 
fields have on the kinetic parameters of L. tarentolae SAPs are also reported. 
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 CHAPTER I  
INTRODUCTION 
Leishmania, Leishmaniasis, and Current Treatment Options 
Leishmaniasis is defined by the Center for Disease Control and Prevention as a neglected 
tropical disease carried by the sand fly vector. It affects populations in Asia, India, the Middle 
East, Africa (particularly in the tropical region and North Africa, with some cases elsewhere), 
Central and South America and southern Europe (Leishmaniasis, 2016). No cases of 
leishmaniasis have been reported in Australia or the Pacific islands. This disease is caused by 
any of 20 species of the parasitic protozoan Leishmania (Leishmaniasis, 2016). Leishmaniasis 
presents clinically in three forms: visceral, cutaneous, and mucocutaneous (Leishmaniasis, 
2016). Over 1.6 million new cases of leishmaniasis are reported yearly (Leishmaniasis, 2016), 
and current treatment options include: pentavalent antimony salts, amphotericin B, liposomal 
amphotericin B, ketoconazole, itraconazole, and fluconazole (Leishmaniasis Professionals, 
2016). Treatments can cost from $ 20-$252 USD per day, and treatments can last from 20 days 
to 4 months or longer depending on how long it takes for the lesion to heal (World Health 
Organization Leishmaniasis Treatment Cost, 2017). Leishmania diseases are becoming more 
wide spread, and there are few good drug therapies, thus new directions of treatments should be 
explored. As a consequence of sequencing Leishmania major and Leishmania infantum 
genomes, a large number of potential new drugs targets have been identified (Chawla, 
Madhubala, 2010). These potential drug targets include: the sterol biosynthetic pathway, the 
glycolytic pathway, the purine salvage pathway, nucleotide transporters, purine salvage enzymes, 
the glycosylphosphatidylinositol (GPI) pathway, protein kinases, mitogen-activated protein 
kinases (MAP kinases), proteinases, folate biosynthesis, the glyoxalase system, the trypanothione 
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pathway, topoisomerases, and the hypusine pathway (Chawla, Madhubala, 2010). However, non-
drug treatments affecting these or other potential targets may also be of value in treating 
leishmaniasis. 
Phosphatases 
Phosphatases are hydrolytic enzymes (EC 3.1) that are responsible for the hydrolysis of 
phosphoesters from substrate producing a phosphate and an alcohol (ExPASy, 2016). There are 
three general types of phosphatases; acid phosphatases, neutral phosphatases, and alkaline 
phosphatases (Vincent, Crowder, Averill, 1992; Gani, Wilkie, 1997). These enzymes are 
categorized based upon their pH optimum. Most relevant to this thesis work are acid 
phosphatases. Acid phosphatases are located, in humans, in the cellular components of bone, 
spleen, kidney, liver, intestine, and are also found in the blood (Henneberry, Engel, Grayhack, 
1979). The pathogenesis of Leishmania changes during the life cycle from the amastigote form 
to the promastigote form of the parasite. (Mojtahedi, Clos, Kamali-Sarvestani, 2008). In vitro 
parasites in the stationary phase of their growth curve are more infective to macrophages than are 
parasites in the logarithmic phase (Mojtahedi et al., 2008). It has also been reported that the 
kinetic parameters of secreted acid phosphatases isolated from the in vitro stationary phase of 
Leishmania major change, such that the enzymes have a larger Vmax and a smaller Km compared 
to the logarithmic phase enzyme (Navabi, Soleimanifard, 2015). Leishmania secreted acid 
phosphatases are established to play several roles during the life cycle of the parasite, including: 
aiding in the survival of the parasite in the sand fly alternative host (Fernandes, Soares, Saraiva, 
Meyer-Fernandez, Souto-Padron, 2013), and formation of the parasitophorous vacuole, thus 
preventing macrophages from forming hydrogen peroxide (M. Baghaei, M. BAGHAEI, 2003). 
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Thus, Leishmania secreted acid phosphatases are of interest as potential pharmaceutical targets 
for the treatment of leishmaniasis.  
L. tarentolae Secreted Acid Phosphatase Enzymes 
Secreted acid phosphatase enzymes are defined as proteins with phosphatase activity that 
are released from cells into the medium. In general, they are large molecular weight glycoproteins 
that in some Leishmania species are reported to be up to 70 % (w/w) carbohydrate (Ilg, Stierhof, 
Etges, Adrian, Harbecke, 1991). These proteins have both N- and O- linked sugars. The O-linked 
carbohydrate polymers are reported to be up to 32 repeat units in length (Lippert, Dwyer, Li, 
Olafson, 1999). There are at least two genes reported for Leishmania (Shakariana, Ellisa, 
Mallinsonac, Olafsonb, Dwyera, 1997). Furthermore, it is reported that these enzymes promote 
parasite survival in the sand fly, and promote the formation and evolution of the parasitophorous 
vacuole, in host macrophages, by dephosphorylating macrophage membrane proteins, thus 
preventing macrophage hydrogen peroxide production (M. Baghaei, M. BAGHAEI, 2003). 
Furthermore, the flagellar pocket of Leishmania is specialized, and is the location for the discharge 
of the two different secreted acid phosphatases, the most regularly secreted protein for Leishmania 
major, the human parasite (Isnard, Shio, Oliver, 2012; Fernandes et al., 2013). L. tarentolae, which 
infect reptiles but not humans, have also been shown to secrete acid phosphatases (Mendez, 
Dorsey, McLauchlan, Beio, Turner, Nguyen, Su, Beynon, Friesen, Jones, 2014).  
L. tarentolae  serves as a good model system for the investigation of the two Leishmania 
secreted acid phosphatases for several reasons. First, L. tarentolae are easy to grow, and their 
growth in culture is easily assessed. L. tarentolae do not infect humans, thus are less risky to work 
with. L. tarentolae have utility in the macrophage model system used to assess infectivity. Finally, 
L. tarentolae are sensitive to current treatment options, thus therapeutics that are effective in this 
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model system may also work on the L. major species (Taylor, Munoz, Cedeno, Velez, Jones, 
Robledo, 2010). Furthermore, to test the role of N-linked carbohydrate found on L. tarentolae 
secreted acid phosphatases, cell supernatants containing these enzymes can be incubated with 
PNGase F, a glycosidase. PNGase F is a glycoaminidase, thus cleaving the N-C bond between 
asparagine and N-acetylglucosamines (PNGase F, 2017). These incubations will allow the 
investigation of the role of N-linked carbohydrate in secreted acid phosphatase enzyme activity.   
Electric Fields Applied as a Therapeutic, in General 
Electromagnetic fields are composed of an electric component, and a perpendicular 
magnetic component. When applying an electric field to a biological sample, two types of 
processes may occur: Faradaic or non-Faradaic processes. Faradaic processes are electron 
transfer reactions, where as non-Faradaic process involve reorientation of solvent molecules and 
charges at the electrode surface (Merrill, Bikson, Jefferys, 2005). Electrons move from potentials 
that are more negative to potentials that are more positive. When applying cathodic current 
(negative voltage) to a biological sample, thus making the sample’s potential more positive than 
the electrode, electrons move from the electrode to the sample. Cathodic current (Cat.) is thus 
reductive to the sample. Furthermore, while making the medium of the biological sample more 
negative, the cell potential becomes more positive. The cell potential is relative and is based on 
the charge outside of the cell versus the charge on the inside of the cell. As the exterior of the 
cell becomes more negative, the interior of the cell becomes relatively more positive, thus 
potentially causing depolarization for voltage-gated processes (Biophysics of Membrane 
Potential, 2017). When applying anodic current (positive voltage), the biological sample 
becomes more negative, thus electrons are transferred from the sample to the electrode (Merrill 
et al., 2005). Anodic current (And.) is thus oxidative to the biological sample. Furthermore, 
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while making the medium of the biological sample more positive, the cell potential becomes 
more negative. As the exterior of the cell become more positive, the interior of the cell becomes 
relatively more negative, thus potentially causing hyperpolarization for voltage-gated processes 
(Biophysics of Membrane Potential, 2017). The Food and Drug Administration has approved the 
application of electromagnetic fields, with differential properties, for the following indications: 
electric bone growth stimulators, for the treatment of non-union fractures, failed joint fusion 
following arthrodesis, failed spinal fusion, congenital pseudoarthritis, palliative treatment of 
post-operative edema and pain, and major depressive disorder  (Holden, 2017).  Many of the 
mentioned potential drug targets for the treatment of leishmaniasis have some component that is 
voltage regulated. Some examples include the following. The movement of acetyl-CoA from 
within the mitochondria to the cytoplasm that requires transport of pyruvate across the inner and 
outer mitochondrial membranes. The outer mitochondrial membrane pyruvate transporter is a 
voltage regulated membrane protein (King, 2017). MAP kinases have been reported to be 
regulated by a calcium/calmodulin-dependent protein kinase cascade that is itself regulated by 
secondary messenger Ca2 + (Enslen, Tokumitsu, Stork, Davis, Soderling, 1996). If calcium 
concentrations in cells are affected by the movement of calcium inward through voltage gated 
calcium transporters, these processes will be impacted. The importance of these processes in 
normal cellular metabolism warrant the investigation of their response to the application of an 
electric field for therapeutic treatment of leishmaniasis.  
As a therapeutic, electricity has been applied to L. major in culture, and has been applied 
to two different types of mouse models, Naval Medical Research Institute (NMRI) strain or Bagg 
Albino (BALB/c) strain, for the treatment of pre-existing L. major lesions (Hejazi, Eslami, 
Dalimi, 1972). These authors tested the following conditions: 3, 6, 9, or 12 Volts with current 
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ranging from 0.19-10.65 mA (Direct current). Their in vivo experiments showed that when the 
electrodes were placed 2 cm apart, direct voltages of 3, 6, 9, and 12 volts at various currents 
killed all L. major promastigotes. Furthermore, when the electrodes were 2 cm apart, the 
application of 3 volts for 10 minutes caused the pH to drop from 7 to 4. This drop in pH has 
several physical and chemical implications. First, the drop in pH occurred due to the oxidation of 
water (see equation 1).  
2 H2O (l)  4 H+ (aq) + 4 e- + O2 (g)       Equation 1. 
Because electrons were removed from water to produce protons (hence the drop to more acidic 
pH), we infer that the driving force for this reaction was the applied voltage. To cause the oxidation 
of water, this applied potential must have been anodic, or positive voltage, in character. Thus, these 
authors investigated the effects of anodic waveforms on L. major.  
Hejazi et al. (1972) treated L. major infected mice with electricity that was applied twice a 
week for three weeks after the inoculation of 4-6 week old mice (NMRI or BALB/c) with L. major 
(106 stationary phase parasites). The diameter of skin lesions was measured as a metric to 
determine the effectiveness of the electrical therapies. The NMRI mice with infection, but with no 
treatment, reached a maximum lesion diameter of ~4 mm and spontaneously healed completely by 
week 10. The NMRI mice with infection and electrical therapeutic (3 V, 0.05 mA for 10 min) 
reached a maximum lesion diameter of 2.5 mm, and were healed completely at 6 weeks. Thus, in 
the NMRI mice, electricity was therapeutic, and lead to remission of lesions with no reoccurrence 
up to 23 weeks (the duration of the study). It should be noted that the control mice were also in 
complete remission at 23 weeks, but their remission took longer to initiate (10 weeks).  The 
BALB/c mice with infection, but with no treatment, reached a maximum lesion diameter of ~16 
mm and were all dead by week 20. The BALB/c mice with infection and electrical therapies (3 V, 
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0.05 mA for 10 min) reached a maximum lesion diameter of ~17 mm, and were still alive at 23 
weeks. The electricity treated mice had lesions the same size as the control from weeks 1-3. At 
week 3 electricity treatment occurred, and the control lesions continued to grow while the treated 
lesions reached a minimum of ~0 mm at week 8. On week 9 the treated lesions began to grow 
linearly, and reached a maximum diameter of ~ 17 mm at week 23, at which point the study ended 
(Hejazi et al., 1972). These data indicate that electricity applied as a therapeutic does have an effect 
on lesion size, but depending on the species of mouse, the lasting effect is different, and thus 
different therapeutic durations may be required. The authors did not speculate on the therapeutic 
mechanism.  
Electric Fields for the Purpose of Affecting L. tarentolae Motility, Clumping, Cell Viability, 
and Secreted Acid Phosphatase Activity 
With this in mind, we propose evaluating the effects of applying electric fields to L. 
tarentolae. We wanted to test the ability of L. tarentolae to secrete acid phosphatases, the 
catalytic activity of secreted acid phosphatases, as well as cell motility (as evaluated by 
microscopy), and cell viability (MTT assay).  We are especially interested in the potential effect 
of the application of an electric field to induce or inhibit the release of secreted acid phosphatase 
from Leishmania since it had reported that Leishmania secreted acid phosphatase (SAP) has an 
important role in the infectivity by Leishmania (Vannier-Santos, Martiny, de Souza, 2002).  
Thus, these data have implications for clinical treatments of cutaneous Leishmania infections. 
Vanadium Background, Vanadium Human Exposure, Vanadium Chemistry and 
Speciation 
Vanadium, element number 23, is found in the soil, water and air, and can enter the 
human body through the lungs or digestive tract (Agency for Toxic Substances and Disease 
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Registry, 2016; Rehder, 2013).  Atmospheric vanadium is found in dust, marine aerosol, and 
volcanic emissions. Air is typically not a large source of vanadium exposure for humans. 
Cigarette smokers are exposed to approximately 4 µg of vanadium per cigarette smoked (Agency 
for Toxic Substances and Disease Registry, 2016). Water and soil are likely the greatest sources 
of vanadium, other than food supplements, that humans are exposed to. Water and soil can 
typically contain 0.04-220 µg/L vanadium (Agency for Toxic Substances and Disease Registry, 
2016). The typical total amount of vanadium in humans is 1 mg (Rehder, 2013). Vanadium is a 
very versatile element and has 5 common oxidation states available, with the vanadium (V) 
oxidation state being the overwhelmingly dominant species in aqueous solution. Vanadium 
forms covalent adducts with oxygen, which produce numerous different species of vanadium in 
its (V) oxidation state as a function of pH (Figure 1, Baes, Mesmer, 1976). 
Speciation of vanadium, specifically decavanadate speciation in acidic media, has been 
investigated (Figure 1, Baes, Mesmer, 1976). It is clear that under acidic conditions, protonation 
status changes either by deprotonation or cation exchange with the medium, and vanadium 
speciation is a function of vanadium concentration, solution pH, and ionic strength of the 
solution (F. Rossotti, H. Rossitti, 1956; Corigliano, Pasquale, 1975). Because of this, vanadium 
speciation, degree of protonation, and degree of proton displacement by cations in solution are 
likely different for solutions of different composition. Therefore, when using decavanadate or 
orthovanadate as inhibitors of phosphatases, it is not always clear what species are present, or 
what species are responsible for inhibition of the enzyme being assayed.  
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Figure 1. Vanadium (V) speciation as a mole fraction of total vanadium present at a given pH, 
over the typical pH scale (0-14) (Baes, Mesmer, 1976). This speciation diagram is for a 0.1 m 
vanadium solution 
 
 
 
Vanadium is a Potential Medicinal Agent as a Phosphatase Inhibitor 
It is well known that oxovanadium species act as phosphatase inhibitors (VanEtten et al., 
1974; Abbott, Jones, Weinman, Bockhoff, McLafferty, Knowles, 1979; Knowles, 1980; Gressor, 
Tracey, Stankiewwicsz, 1987; Gordon, 1991; Li, Baruah, Crans, Wang, 2008;). How vanadium 
acts as a phosphatase inhibitor is thought to be through the action of a vanadium (V) monomeric 
oxyanion, vanadate, mimicking a 5 coordinate high energy intermediate of the transition state 
phosphate, therefore behaving as a competitive inhibitor (Abbott et al., 1979; Knowles, 1980; 
Rehder, 2013). There are numerous crystal structures of phosphatases, with nitrogen-containing, 
oxygen containing, or sulfur-containing active site amino acids, deposited in the Protein Data 
Bank, that have been recently reviewed (McLauchlan, Peters, Willsky, Crans, 2015). These 
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phosphatases function to hydrolyze esters, phosphoesters, and phosphoanhydrides. These crystal 
structures had been soaked with vanadium complexes, the majority of experiments using 
orthovanadate, at pH values ranging from 5.40-8.00. The overwhelming majority of these 
phosphatases, regardless of the type of active site amino acid residues (O, N, or S containing), 
have a monomeric form of vanadium (VO32- or VO43-) present in the phosphatase active site 
upon solving the crystal structure. It should be noted at the used concentrations of vanadium and 
in this pH range, that di-, tri-, and tetrameric vanadium species are predicted to be the major 
forms of vanadium present, and not the monomeric forms (VO32- or VO43-) that are reported in 
the enzyme’s active site. Thus, there is a discrepancy between what one might hypothesize about 
the species responsible for inhibition (the major species present is responsible for the inhibition), 
and what one actually finds (a minor species present is responsible for the inhibition). 
Regardless, it is thought that these monomeric species are likely responsible for phosphatase 
inhibition. There is, however, a likely discrepancy between solid state speciation of vanadium 
that occurs under soaking conditions, and aqueous speciation of vanadium that occurs in 
enzymatic assays because crystal dynamic conditions are likely to be different than those of the 
more flexible protein under enzymatic assay conditions in terms of pH, ionic strength, and 
vanadium concentration. Therefore, the species of vanadium present in enzymatic assays cannot 
necessarily be assumed to be the same as the species present after crystal soaking experiments. 
To further stress the importance of speciation, crystallographic soaking studies that used 
metavanadate (50 mM) starting material, under acidic conditions (pH 5.0) produced protein 
crystals of B. stearothermophilus phosphatase with trivanadate, V3O82-, located in the putative 
active site, when in fact, the authors had expected to find orthovanadate, VO43- (PDB ID 1h2f., 
Rigden, Littlejohn, Henderson, Jedrzejas, 2003).  
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Using acid phosphatase amino acid sequence alignment from rat (APR. norvegicus 
EC3.1.3.2, PDB 1rpt) as a comparative model to Leishmania secreted acid phosphatases, it can 
be seen that there is in fact overlap between the reported vanadate binding residues in the APR. 
norvegicus and the L. mexicana acid phosphatases (SAP1L.mex gene accession number 
Z46969.1 and SAP2L.mex gene accession number Z46970.1). The gray and black highlights are 
the amino acids reported to be in the active site. Gray highlights indicate different amino acids 
between species. Black highlights indicate identical amino acids between species. Using the 
amino acid numbering from APR. norvegicus, the following residues are responsible for 
coordinating vanadate, Arg11, His12, Arg15, Arg79, and His257, and are highlighted in red in 
Figure 2. 
 
 
 
Figure 2. Multiple Sequence Alignment of three acid phosphatases. This sequence alignment was 
completed using Kalign and the BoxShade Server (Kalign, 2016; BoxShade Server, 2017) 
 
 
 
To further investigate the ambiguities of vanadium speciation and phosphatase inhibition, 
we use a previously published model (Baumhardt, Dorsey, McLauchlan, Jones, 2015) for 
comparing competitive enzyme inhibitors to compare decavanadate and orthovanadate as 
inhibitors of L. tarentolae secreted acid phosphatases. These studies can give insight into the 
clinical use of these and other vanadate complexes as anti-Leishmania therapies.  
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Because leishmaniasis is an endemic disease with costly treatment options, and multiple 
cellular targets, including acid phosphatases, here we investigated the effects that electric fields, 
with or without the presence of vanadium complexes, or glycosidase preincubation have on L. 
tarentolae in vitro for the purpose of discovering new, cheap therapeutics for the treatment of 
leishmaniasis. 
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CHAPTER II 
MATERIALS AND METHODOLOGY 
Cell Culture of L. tarentolae and Assessment of Cell Viability by the MTT Viability Assay 
L. tarentolae (ATCC 30143) promastigote cells were sterilely grown in brain heart 
infusion (BHI; 37.0 g/L) supplemented with hemin (10 µM), penicillin (10,000 units/ mL) and 
streptomycin (10 mg/ mL) following a published method (Morgenthaler, Peters, Cedeno, 
Constantino, Edwards, Kamowski, Jones, 2008). L. tarentolae cell viability was assessed by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay (Mosmann, 
1983). The MTT assay serves as a quantitative measure (A595 nm) of cell mitochondrial 
activity, and therefore indirectly monitors cell viability. Sample absorbance at A595 nm was 
determined with an iMark microplate reader (BioRad Laboratories, Hercules, CA). The BHI 
growth medium alone was considered as a blank value subtracted from the sample absorbance 
(BHI and cells). Results are reported as corrected absorbance (A595 nm/Hr incubation with MTT 
reagent, or A595 nm/Hr incubation with medium only) mean ± standard deviation (SD) for n = 4 
replicates. In all cases where error bars less than 5 % were not shown. In this work, the parasites 
were grown at room temperature in 25 cm2 canted flasks (Corning, Inc.; Product number 
430372). Samples for assessment by MTT assay were collected daily using sterile technique.   
Microscopy of L. tarentolae  
Microscopic analysis of L. tarentolae for motility, shape, and clumping was undertaken. 
The parasites were observed microscopically to monitor the effect of each treatment on the 
parasite. A Jenco International, Inc. (Portland,OR) inverted compound microscope Model CP-
2A1 was used. This microscope can be adjusted to focus on cells at the bottom, middle, or upper 
focal planes of the culture flask which will allows observations of the parasite throughout the 
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culture medium. Images of cells (at 400x magnification) were taken using the camera on the 
Google Pixel cellular phone. Microscopy was performed on all L. tarentolae cell cultures daily.  
Preparation of the L. tarentolae Acid or Alkaline Phosphatase Enzyme Source 
A sample of L. tarentolae  from each stage of the growth curve (lag, log, stationary, and 
senescence) was collected and centrifuged (2000xg, 10 ºC, 10 minutes). The supernatant was 
collected and stored on ice until it was used for acid or alkaline phosphatase enzyme assays. The 
pellet was immediately resuspended in a volume of BHI equal to the volume of supernatant 
collected from that same sample. The pellets were then stored on ice until they were used in acid 
or alkaline phosphatase enzyme assays.  
Secreted Acid or Alkaline Phosphatase Enzyme Assay 
Secreted acid or alkaline phosphatase (SAP) activity was evaluated using para-
nitrophenyl phosphate (pNPP) as substrate following the method of Mendez et al. (2014). This 
assay at room temperature was performed in 1.5 mL polypropylene tubes in a total reaction 
volume of 0.9 mL. Sodium acetate buffer (500 µL, 0.5 M, pH 4.5) was used for acid phosphatase 
assays. Tris-Base (500 µL, 0.5 M, pH 8.3) was used for alkaline phosphatase assays. The enzyme 
source was L. tarentolae cell supernatant or pellet from each phase of the growth curve (300 µL). 
The substrate (5 mg pNPP/1mL buffer), made in sodium acetate buffer (0.5 M, pH 4.5) for acid 
phosphatase assays, or Tris-Base (0.5 M, pH 8.3) for alkaline phosphatase assays was added (100 
µL ) to start the reaction (500 µM final concentration). After room temperature incubation for 23 
hours, the reaction was stopped with addition of 100 µL of 10 M sodium hydroxide, and samples 
were vortexed. Product formation was measured by spectroscopy at A405 nm. BHI was used to 
replace enzyme source for spectrophotometric blanks. Data are reported as absorbance (A405 
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nm) per day in culture. Product (para-nitrophenolate) was calculated from corrected A405 nm/23 
Hr divided by molar absorptivity (18,000 cm-1* M-1) and reported as µM/ 23 Hr. 
Kinetic Enzyme Assay 
The order of addition of material to the kinetic enzyme assay was as follows. Sodium 
acetate buffer (500 µL, 0.5 M, pH 4.5) was used for acid phosphatase assays. The artificial 
substrate, para-nitrophenylphosphate (pNPP), was freshly prepared in buffer, then it was added 
to the assay to give final substrate concentrations of 2.0, 2.6, 3.0, 3.4, 3.7, 4.1, 4.5, 6.0, 8.8, 12.0, 
14.0, 18.0, 150.0, 200.0, 250.0, 300.0, 350.0, 400.0, 450.0, 500.0, 550.0, 1000.0, 2000.0, or 
4000.0 µM. Lastly, log phase L. tarentolae cell supernatant as enzyme source (300 µL) was 
added to the 1.5 mL polypropylene tubes to start the reaction. The final assay volume was 0.9 
mL (n=3). Assays were incubated at room temperature for 23 hours, previously determined to be 
under apparent first order conditions (Mendez et al., 2014), in the dark. To stop the reaction, 
sodium hydroxide (100 µL, 10 M) was added and the samples were vortexed. Product was then 
evaluated by spectroscopy (A405 nm). Spectrophotometric blanks were prepared using the same 
volumes of assay buffer and substrate as experimental samples, but the enzyme source was 
replaced with brain heart infusion medium, the same medium as the supernatant fraction, but not 
exposed to cells. 
Designing Waveforms for the Production of Electric Fields  
Using a comma-separated values (CSV) excel file, the waveforms to be applied to L. 
tarentolae whole cells or cell supernatant were generated. The number of data points (N) is used 
to determine the time resolution (S) of the signal. The resolution of the signal is the time between 
current applications. The larger the number of data points (N), the smaller the resolution (S) is.  
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For these experiments, N = 40,000. The frequency (F), defined as a cycle per second, was then 
used to calculate the period (T) of the waveform. 
T = 1/F          Equation 2 
The period and number of data points were used to calculate the resolution of the signal (S). 
S = T/N          Equation 3 
The excel file contained two columns, one column for time, and the other for the voltage 
that is entered into the waveform generator. Time zero will have a value of 0S. Time 1 will have 
a value of 1S. Time two will have a value of 2S, and so on to fill the 40,000 data points. The 
value of the voltage in the other column was either be zero or four. When the value is equal to 
zero, then zero voltage will be applied. When the value is equal to four, then an input of four was 
sent to the waveform generator (Singlet Function/Arbitrary Waveform Generator) and voltage 
was then generated from the electrode. To determine when the values of voltage are zero or four, 
the period of the waveform (T) was divided by three to generate three equal time points; the 
pulse width (PW), the interphase delay (IPD) and the space between cycles (CS). These three 
values add up to equal the period (T).  
T = 2PW + IPD + CS         Equation 4 
When the period is divisible by three, producing an integer value, the value of CS is equal 
to zero. When the period is not divisible by three, producing a non-integer value, the value of CS 
is the smallest value that will produce a period divisible by three. The following equations are 
also true: 
PW = IPD          Equation 5 
PW = (T-CS)/3         Equation 6 
PW = T/3 if CS = 0         Equation 7 
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To generate Figure 3, a data file containing forty thousand data points, N = 40,000, was 
used. For a frequency of 5000 Hz, F= 5000 s-1, thus T = 1/F, T = 1/5000, T = 2 * 10-4 seconds. 
The resolution was calculated as S = T/N, S = (2*10-4 seconds)/40,000, S = 5*10-9 seconds. The 
time points in the excel file started at zero and grew in increments of 5*10-9 s at each iteration. 
To determine the time of PW, and thus IPD, the period (T = 200 µs) must be divided into three 
equal parts. To do this, CS will have a value of 2 µs. Using equation 5, PW will be determined.  
PW = (T-CS)/3, PW = (200 µs - 2 µs)/3, PW = 66 µs 
PW, as calculated for a symmetric waveform, means the cathodic segment will be 66 µs 
and the anodic segment will be 66 µs. Using equation 4, IPD will be determined.  
IPD = PW, IPD = 66 µs 
 
 
 
Figure 3. A plot of time (µs) vs. voltage (mV) is shown for a symmetric biphasic waveform 
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In an excel file, the following spread sheet was written to generate the waveform in 
Figure 3. From 0-2 µs (The CS), in increments of 0.005 µs (Resolution, S), the voltage input was 
assigned to 0, thus producing 0 mV (CS1). This occupies 400 data points. From 2-68 µs, the 
voltage was assigned to 4, thus producing -180 mV (PWCat). This occupies 13,200 data points. 
From 68-134 µs, the voltage of 0 was assigned, thus producing 0 mV (IPD). This occupies 
13,200 data points. From 134-200 µs, the voltage of 4 was assigned, thus producing 180 mV 
(PWAnd). This occupies 13,200 data points. All 40,000 data points are thus be accounted for. CS2 
immediately follows PWAnd, and will have identical parameters of CS1. CS2 is the space between 
cycle one and cycle two. 
Electrode Tested 
The electrode used was a concentric bipolar electrode from FHC Neuro Micro 
TargetingTM Worldwide. Figure 4 is a model of the general shape of the electric fields that are 
applied to L. tarentolae whole cells or L. tarentolae cell supernatant. 
 
 
 
Figure 4.  Model of the general shape of the electric field that is applied to either L. tarentolae 
whole cells or cell supernatant is shown 
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Parameters of Tested Waveforms 
The waveforms were loaded on to a singlet arbitrary waveform generator. The following 
parameters of the waveform that produces the electric filed were modified using an isolator 
(World Precision Instruments stimulus isolator): frequency (50-10,000 Hz), current (0.1-1.0 
mA), polarity of the waveform (symmetric biphasic, cathodic, or anodic), and exposure time (2.5 
min-12 hours ) to the electric field. A simplified model of the experimental setup is shown in 
Figure 5. 
 
 
 
Figure 5. Simplified experimental model of setup to apply electric fields to L. tarentolae whole 
cells or cell supernatant 
 
 
 
Testing the Acute Effects of Electric Fields on L. tarentolae Growth Curves and Microscopy 
L. tarentolae were transferred from 25 cm2 canted flasks into 24 well plates (Falcon; 0.5 
mL per well), taking care to deliver a consistent number of cells  to each well. Using a singlet 
arbitrary waveform generator coupled to a stimulus isolator, an electrode was applied to these 
cells to expose them to a characterized electric field for a specific amount of time. After 
exposure to the electric field, L. tarentolae were assessed for cell viability by the MTT assay. 
Immediately following the application of an electric field, these cells were monitored by 
microscopy. Results were compared to cells not exposed to the electric field.  
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Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pellet (Cells), Method 1 
L. tarentolae were collected from the log phase of their growth curve, centrifuged 
(2000xg, 10 min, 10 ºC), and the supernatant was collected. The cell pellet was resuspended in a 
volume of BHI growth medium equal to the volume of supernatant collected. The supernatant or 
pellets were transferred  into a 24-well plate (Falcon, 0.5-2.0 mL per well). Using a singlet 
arbitrary waveform generator coupled to a stimulus isolator, a concentric bipolar electrode was 
applied to these samples to expose them to an electric field, or not (control). The samples 
exposed to the same type of electric fields, or not (control), were pooled and rested on ice until 
they were assessed by the acid phosphatase enzyme assay. The process is outlined in the flow 
diagram below in Figure 6. Data are plotted as percent different from same time control for n=3. 
Data were first evaluated by ANOVA, and those that were significantly different were further 
analyzed. When reporting percent different relative to the same time control, only those data that 
were statistically different in a paired, two-tailed t-test at the 0.05 level were reported.  
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Figure 6. Flow diagram of Method 1. Thus, method 1 allows testing of direct effects of electric 
field on the previously secreted enzyme 
 
 
 
Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pellet (Cells), Method 2 
L. tarentolae were collected from the log phase of their growth curve, and were then 
transferred from culture flasks to 24-well plates (Falcon, 0.5-2.0 mL per well), taking care to 
deliver a consistent number of cells to each well. Using a single arbitrary waveform generator 
coupled to a stimulus isolator (World Precision Instruments), a concentric bipolar electrode was 
applied to these samples to expose the cells an electric field, or not (control). The cells were 
collected. Cells that were exposed to the same type of electric fields or control cells were pooled. 
These pools were centrifuged (2000xg, 10 min, 10 ºC), and the supernatant was collected. The 
cell pellets were resuspended in a volume of BHI equal to the volume of the supernatant 
collected. The samples were rested on ice until they were used in the acid phosphatase enzyme 
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assays. The process is outlined in Figure 7. Data are plotted as percent different from same time 
control for n=3. Data were first evaluated by ANOVA, and those that were significantly different 
were further analyzed. When reporting percent different relative to the same time control, only 
those data that were statistically different in a paired, two-tailed t-test at the 0.05 level were 
reported. 
 
 
 
Figure 7. Flow diagram of Method 2. Thus, method 2 allows assessment of the effect of electric 
field on secretion of acid phosphatase from cells 
 
 
 
Secreted Acid Phosphatase Enzyme Inhibition Assay (Following the Method of Baumhardt 
et al., 2015) 
To determine which form of vanadium is most useful in L. tarentolae secreted acid 
phosphatase enzyme assays, decavanadate or orthovanadate, the method of Baumhardt et al. 
(2015) was used. Using the previously determined kM substrate concentration of 391 µM, the log 
ratio of substrate to total vanadium concentration in the assay was calculated for either 
orthovanadate or decavanadate (as shown in Table 1). This amount of substrate was used as a 
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first approximation of kM from previous work (Mendez et al., 2014) with the same enzyme 
source. 
 
 
Sample log[S]/[I] [Total Vanadium] mM [Decavanadate] mM [Orthovanadate] mM 
1 -2.0 3.91E+01 3.91E+00 3.91E+01 
2 -1.5 1.24E+01 1.24E+00 1.24E+01 
3 -1.0 3.91E+00 3.91E-01 3.91E+00 
4 -0.5 1.24E+00 1.24E-01 1.24E+00 
5 0.0 3.91E-01 3.91E-02 3.91E-01 
6 0.5 1.24E-01 1.24E-02 1.24E-01 
7 1.0 3.91E-02 3.91E-03 3.91E-02 
8 1.5 1.24E-02 1.24E-03 1.24E-02 
9 2.0 3.91E-03 3.91E-04 3.91E-03 
Table 1. The concentrations of vanadium used as either total vanadium, or orthovanadate, or 
decavanadate in each sample. 
 
 
 
Table 1 indicates the relationship between the log of substrate to inhibitor ratio to the 
total moles of vanadium, or the total moles of decavanadate, or the total moles of orthovanadate 
in the assay. It should be noted that for every mole of orthovanadate, there is one mole of 
vanadium. For every mole of decavanadate, there are ten moles of vanadium. Thus, 
orthovanadate was used at ten times the molar concentration of decavanadate, but the total moles 
of vanadium from either compound, in the assay, was the same as listed in Table 1. In all cases 
the concentration of the artificial substrate, para-nitrophenylphosphate (pNPP), is 391 µM.   
The order of addition of material to the assay was as follows. Sodium acetate buffer (0.5 
M, pH 4.5), vanadium as either orthovanadate or decavanadate freshly prepared in assay buffer, 
and enzyme source (300 µL of log phase L. tarentolae cell supernatant) were added to the assay 
and allowed to preincubate at room temperature for 10 minutes. The artificial substrate, para-
nitrophenylphosphate (pNPP) was added to the assay to give final concentrations of 391 µM 
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pNPP. The final assay volume was 0.9 mL. Assays were incubated at room temperature for 23 
hours. To stop the reaction sodium hydroxide (100 µL ,10 M) was added and the samples were 
vortexed. Product was evaluated by spectroscopy at A405 nm. Spectrophotometric blanks were 
prepared using the same volumes of assay buffer, vanadium as either orthovanadate or 
decavanadate, and substrate as experimental samples. The enzyme source was replaced with 
brain heart infusion, the same medium the enzyme was in for kinetic and inhibition assays. Data 
are reported as mean ± standard deviation for n=4 replicates. 
Secreted Acid Phosphatase Enzyme Inhibition Assays with Pretreatment with Eelectric 
Fields Followed by Incubation with and without Orthovanadate (25 µM)  
To test the effect of pretreating L. tarentolae log phase cell supernatant with electric 
fields followed by incubation with orthovanadate (25 µM), supernatant was collected (50 mL) 
from the stationary phase of the growth curve, exposed to electric fields, and then used as the 
enzyme source for end point acid phosphatase assays. This concentration of orthovanadate was 
selected based on the experiments done using the model reported by Baumhardt et al., 2015. This 
concentration of orthovanadate inhibits L. tarentolae secreted acid phosphatase activity, but does 
not completely shut down the enzyme. Thus, if a synergistic effect occurs between orthovanadate 
and electric field application, and is large enough, it can be measured. The order of addition of 
material to the assay was as follows. Sodium acetate buffer (0.5 M, pH 4.5), orthovanadate 
freshly prepared in assay buffer, and enzyme source (300 µL) were added to 1.5 mL 
polypropylene tubes for the assay and allowed to preincubate at room temperature for 10 
minutes. The artificial substrate, para-nitrophenylphosphate (pNPP) was added to the assay to 
give a final concentration of 391 µM pNPP. The final assay volume was 0.9 mL. Assays were 
incubated at room temperature for 23 hours. To stop the reaction sodium hydroxide (100 µL, 
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10 M) was added and the samples were vortexed, and product was evaluated by spectroscopy 
A405 nm. 
Secreted Acid Phosphatase Kinetics Assay with and without the Preincubation with a 
Glycosidase, Followed by Pretreatment with and without Electric Fields 
The L. tarentolae log phase cell supernatant was collected via centrifugation (2000xg, 10 
min, 10 ºC), incubated with the glycosidase PNGase F (10 µL of PNGase F with activity of 10 
U/ µL per 25 mL enzyme pool; Promega Madison, WI) enzyme source for 24 hours at room 
temperature, and then this enzyme pool was used in kinetic assays. The order of addition of 
material to the assay was as follows. Sodium acetate buffer (500 µL, 0.5 M, pH 4.5) was added 
to 1.5 mL polypropylene tubes. The artificial substrate, para-nitrophenylphosphate (pNPP), was 
freshly prepared in buffer, then it was added to the assay to give final substrate concentrations of: 
2.0, 2.6, 3.0, 3.4, 3.7, 4.1, 4.5, 6.0, 8.8, 12.0, 14.0, 18.0, 150.0, 200.0, 250.0, 300.0, 350.0, 400.0, 
450.0, 500.0, 550.0, 1000.0, 2000.0, or 4000.0 µM. Lastly, L. tarentolae cell supernatant as 
enzyme source (300 µL) was added to the 1.5 mL polypropylene tubes. The final assay volume 
was 0.9 mL (n=3). Assays were incubated at room temperature for 23 hours (previously 
determined to be under apparent first order conditions (Mendez et al., 2014), in the dark. To stop 
the reaction, sodium hydroxide (100 µL, 10 M) was added and the samples were vortexed. 
Product was evaluated by spectroscopy (A405 nm). Spectrophotometric blanks were prepared 
using the same volumes of assay buffer and substrate as experimental samples, but the enzyme 
source was replaced with brain heart infusion medium, the same medium as the supernatant 
fraction, but not exposed to cells. 
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CHAPTER III  
RESULTS AND DISCUSSION 
Cell Culture of L. tarentolae and Assessment of Cell Viability by the MTT Viability Assay 
During their growth curve, L. tarentolae respond in a predictable manner to the MTT 
reagent. This predictable and repeatable response is useful as a metric because it gives a context 
for normal L. tarentolae behavior, and serves a reference point from which enzyme pools, whole 
cells or cell supernatant, are collected. Furthermore, knowing what phase of the growth curve 
cells are in is useful because it allows more accurate interpretation of an effective potential 
treatment. Figure 8 shows a typical growth curve with the four characteristic phases of in vitro 
cell growth exhibited by L. tarentolae.  
 
 
 
Figure 8. A typical growth curve for L. tarentolae with the corrected MTT response plotted on 
the Y-axis and the day in culture plotted on the X-axis. The lag phase occurs on days 1-3. The 
log phase occurs on days 4-5. The stationary phase occurs between days 5-6. The senescence 
phase occurs on days 6-8. Each point is the mean ± standard deviation of n=4 replicates 
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Microscopy of L. tarentolae 
During their growth curve, L. tarentolae exhibit typical behavior that is observable by 
light microscopy. During the lag phase (days 1-3), the cells have a distinct, elongated shape, and 
do not clump. The cells exhibit moderate motility, and the cell population does not appear to be 
over crowded (Figure 9). During the log phase (days 4-5), the cells have a distinct, elongated 
shape, and do not clump. The cells exhibit increased motility, and the cell population appears 
significantly more crowded. Cells exhibit no clumping during this phase (Figure 10). During the 
stationary phase (between days 5-6), the shapes of most cells are still distinct and elongated. 
Some cells begin to appear rounded, and the cell population exhibits variable motility. Some 
cells are moving rapidly, while other cells are not moving at all. The cell population still appears 
crowded during the stationary phase. Cells exhibit clumping during the stationary phase. Each 
cell clump contains between 3 and 10 cells (Figure 11). During the senescence phase (days 6-8), 
the shape of cells becomes increasingly more rounded as the culture ages. The cells that appear 
more rounded in shape, also appear to not be moving. The cells that are more elongated are still 
moving, but with decreasingly less rigor. The cell population appears crowded, but the majority 
of cells are rounded and not moving. Little or no clumping is observed during this phase of the 
growth curve (Figure 12).  
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Figure 9. The above image depicts L. tarentolae by microscopy (400X) during the lag phase of 
their growth curve 
 
 
 
 
Figure 10. The above image depicts L. tarentolae by microscopy (400X) during the log phase of 
their growth curve 
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Figure 11. The above image depicts L. tarentolae by microscopy (400X) during the stationary 
phase of their growth curve 
 
 
 
 
Figure 12. The above image depicts L. tarentolae by microscopy (400X) during the senescence 
phase of their growth curve 
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Secreted Acid or Alkaline Phosphatase Enzyme Assay  
Using the growth curve as a reference point, detectable secreted acid phosphatase activity 
tracks with the MTT response up to day 6, as shown in Figure 13. When the cells’ response to 
the MTT reagent decreases, the detectable secreted acid phosphatase activity plateaus (days 6-8). 
Alkaline phosphatase activity in the supernatant was not detectable during any point of the 8 day 
growth curve, as shown in Figure 13.  
 
 
 
Figure 13. Secreted acid (red curve) or secreted alkaline (lime green curve) phosphatase activity 
detected as a function of day in culture. The blue curve is the typical L. tarentolae growth curve 
evaluated by MTT response. Each point is the mean ± standard deviation of n=3 replicates 
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Kinetic Enzyme Assay 
The L. tarentolae log phase supernatant appeared to exhibit Michaelis-Menten type 
enzyme behavior as a response to increasing substrate concentrations (Figure 14). The response 
depicts an apparent first order portion with a large response to increases in substrate 
concentration. This apparent first order response is followed by a decreased response to 
increasing substrate concentration, thus indicating that VMAX is being approached by the enzyme 
pool. A noticeable derivation from the apparent first order trend occurs at 350 µM pNPP 
(indicated by arrow) was, however, suggestive of non-Michaelis-Menten behavior. It should be 
noted that in this work, VMAX data are not corrected for total amount of enzyme present. 
 
 
 
Figure 14. A typical V versus S curve utilizing L. tarentolae log phase supernatant as the enzyme 
source. Each point is the mean ± standard deviation of n=3 replicates 
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The Lineweaver-Burk linear transformation of the Michaelis-Menten curve, that typically 
produces a single line for a single enzyme source, produced two different lines for the L. 
tarentolae log phase supernatant (Figures 15, 16, and 17).  
 
 
 
Figure 15.  A typical Lineweaver-Burk linear transformation using L. tarentolae log phase 
supernatant as the enzyme source. Enzyme 1 is shown in blue circles. Enzyme 2 is shown in red 
triangles. Each point is the mean ± standard deviation of n=3 replicates 
 
 
y = 9.17x + 4.80E-03
R² = 0.972
y = 0.956x + 0.285
R² = 0.887
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
0.00E+00 1.00E-01 2.00E-01 3.00E-01 4.00E-01 5.00E-01 6.00E-01
1
/ 
[p
ar
a-
n
it
ro
p
h
en
o
la
te
] 
(1
/µ
M
/2
3
 H
r)
1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Log Phase Supernatant Enzyme Kinetics
Enzyme 1
Enzyme 2
Linear (Enzyme 1)
Linear (Enzyme 2)
33 
 
 
Figure 16. A typical Lineweaver-Burk linear transformation using L. tarentolae log phase 
supernatant as the enzyme source. This graph only depicts the response of Enzyme 1 with n=12 
points. Each point is the mean ± standard deviation of n=3 replicates 
 
 
 
 
Figure 17. A typical Lineweaver-Burk linear transformation using L. tarentolae log phase 
supernatant as the enzyme source. This graph only depicts the response of Enzyme 2 with n=12 
points. Each point is the mean ± standard deviation of n=3 replicates 
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Enzyme 1 is present and detectable during the course of the entire eight day growth curve 
(Figure 18). The kM value for enzyme 1 changes subtly as a function of day in culture. The VMAX 
value of enzyme 1 changes with culture age (Table 2 and Figure 18). This change, up to day five 
of the L. tarentolae growth curve, is likely due to increasing cell number, and thus increasing 
amount of total secreted enzyme. The apparent disconnect between the number of viable cells 
and calculated VMax value of enzyme 1 that occurs on day 6-8 of the L. tarentolae growth curve 
may be explained in two ways. It could be that enzyme 1 is resistant to being denatured and 
remains active once secreted into the culture medium. It could also be the case that enzyme 1 is 
stored in L. tarentolae whole cells, and is released upon their death, thus leading to a plateau in 
the calculated VMAX value of enzyme 1, due to an approximately constant amount of enzyme 1 
being present in the culture medium.  Incubation of day 8 supernatant with the glycosidase, that 
has recognition for N-linked carbohydrates, noticeably changed experimental kM and VMAX 
values of enzyme 1 relative to the non-glycosidase treated supernatant. The kM decreased by 24.4 
%, and the VMAX increased by 13.5 % (Table 2). 
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Day in culture KM (µM) 
VMAX  
(µM/23 Hr) 
1 1.36E03±1.3E02 54.9±1.1E-01 
2 1.27E03±1.0E02 57.1±1.0E-01 
3 1.11E03±9.1E01 63.3±9.0E-01 
4 1.27E03±9.0E01 69.4±6.1E-01 
5 1.91E03±1.3E02 208±1.0E01 
6 1.56E03±6.0E01 159±7.0 
7 1.10E03±3.0E01 192±9.0 
8 1.28E03±5.0E01 200±8.0 
8 + Glycosidase 968±1.3E02 227±50 
Table 2. The calculated kM and VMAX values for enzyme 1 from L. tarentolae as a function of 
day in culture 
 
 
 
 
Figure 18. A plot of calculated VMAX value (Y-axis) for enzyme 1 as a function of day in culture 
(X-axis). This value is not a simple function of culture age. Each point is the mean ± standard 
deviation of n=3 replicates 
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Enzyme 2 is not detectable during the first two days of the L. tarentolae growth curve, 
but becomes detectable on day 3 and remains detectable through day 8. The kM value for enzyme 
2 remains in the same order of magnitude from days 3-5 of culture. The kM values from days 6-8 
indicating that enzyme becomes less efficient at binding substrate as the culture ages. The VMAX 
value of enzyme 2 remain consistent with culture age until senescence phase (Figure 19). There 
is a large increase in the VMAX value of enzyme 2 on day 7 of culture (Table 3). This change as 
shown in Figure 19 occurs during the senescence phase of the L. tarentolae growth curve, and 
may indicate that the total amount of enzyme 2 in the culture medium increases as cells die. This 
suggests that the majority of enzyme 2 is stored and is secreted upon external stimulus. 
Incubation with a glycosidase drastically increased experimental kM and VMAX values of enzyme 
2. The kM increased by 92.5 %, and the VMAX increased by 93.4 % compared to non-glycosidase 
incubated control. 
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Day in 
Culture 
KM (µM) 
VMAX  
(µM/24 Hr) 
1 Not Detectable Not Detectable 
2 Not Detectable Not Detectable 
3 2.26±7.20E-02 1.40±2.00E-01 
4 6.93±0.42 3.58±0.12 
5 3.35±7.7E-02 3.51±2.9E-01 
6 10.3±8.1E01 2.82±1.9E-01 
7 36.6±1.8 16.2±7.0E-01 
8 24.8±2.3 7.63±8.4E-01 
8 + 
Glycosidase 
331±14 115±17 
Table 3. The calculated kM or VMAX values for enzyme 2 from L. tarentolae as a function of day 
in culture 
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Figure 19. The calculated VMAX (Y-axis) value for enzyme 2 as a function of L. tarentolae day in 
culture (X-axis). Each point is the mean ± standard deviation of n=3 replicates 
 
 
 
Testing the Acute Effects of Electric Fields on L. tarentolae Growth Curves and Microscopy 
The application of electric fields (50 Hz or 10,000 Hz, 100-500 µA, 30 min, cathodic, or 
symmetric biphasic, or anodic waveforms) to L. tarentolae whole cells followed by the MTT 
viability assay led to no statistically significant results (p <, 0.05 for paired, two tailed t-test; data 
not shown). The application of electric fields did lead to changes in cell clumping (Figures 20-
25). The effect of frequency is observed by comparing Figure 20 to Figures 21 and 22. As the 
frequency increases from 50 Hz to 10,000 Hz, the amount of cell aggregation (clumping) 
drastically increases. The effect of current is observed when comparing Figure 20 to Figures 21 
and 23. There are no large differences between 100 µA and 500 µA, but there is an increase in 
cell aggregation when comparing 50 Hz symmetric biphasic at 100 µA (Figure 23) or 500 µA 
(Figure 21) to control cells (Figure 20). The effect of waveform polarity is observed when 
comparing Figures 20 to Figures 23, 24, and 25. The application of any type of electric field 
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differences is caused by a 50 Hz, 100 µA, anodic electric field (Figure 25). The application of 
this electric field not only caused aggregation of cells, but also caused them to clump. We 
interpret cell clumping as an indication that the cells are stressed.  
 
 
 
Figure 20. L. tarentolae lag phase control cells viewed at 400X magnification 
 
 
40 
 
 
Figure 21. L. tarentolae lag phase cells exposed to an electric field (50 Hz, 500 µA, 30 min, 
symmetric biphasic) viewed at 400X magnification. These cells exhibit several large clumps 
(circled areas) 
 
 
 
 
Figure 22. L. tarentolae lag phase cells exposed to an electric field (10,000 Hz, 500 µA, 30 min, 
symmetric biphasic) viewed at 400X magnification. These cells are completely packed into a 
single area 
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Figure 23. L. tarentolae lag phase cells exposed to an electric field (50 Hz, 100 µA, 30 min, 
symmetric biphasic) viewed at 400X magnification. These cells are more concentrated than 
typical L. tarentolae lag phase cells 
 
 
 
 
Figure 24. L. tarentolae lag phase cells exposed to an electric field (50 Hz, 100 µA, 30 min, 
cathodic) viewed at 400X magnification. These cells are more concentrated than typical L. 
tarentolae lag phase cells 
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Figure 25. L. tarentolae lag phase cells exposed to an electric field (50 Hz, 100 µA, anodic) 
viewed at 400X magnification. The microscopic observations imply that the cells are moving 
toward the electrode during the electrode stimulation 
 
 
 
Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pellet (Cells), Method 1 
In method 1, the L. tarentolae log phase cells are separated, then electric fields (7 
different current conditions, 3 different wave forms, and 2 different frequencies) were applied to 
small volumes (0.5–2.0 mL) of resuspended cell pellets or harvested cell supernatants. The 
samples were then assayed for acid phosphatase activity. For data to be shown, the experimental 
condition must be statistically different from the non-treated control (p < 0.05) in a paired, two 
tailed t-test. The data are plotted as percent different from same time control (Equation 8). A 
positive number means the treatment caused an increase in acid phosphatase activity compared 
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to control. A negative number means the treatment caused a decrease in acid phosphatase 
activity compared to control.  
Equation 8. 
Percent Different = (Experimental Activity – Control Activity)/(Control Activity) * 100 %  
The application of a 50 Hz, cathodic electric field (7 different current conditions) to L. 
tarentolae supernatant or pellet followed by the assessment of acid phosphatase activity resulted 
in measurable effects in both the supernatant and pellet activity that were significantly different 
from their controls. Six out of seven conditions had an effect on supernatant acid phosphatase 
activity, but no consistent trend between current and supernatant activity was observed (Figure 
26). Six out of seven conditions had an effect on pellet acid phosphatase activity, but no 
consistent trend between current and pellet activity was observed (Figure 27). The current 
conditions that affected both the supernatant and pellet acid phosphatase activity were 100, 150, 
200, 250, or 400 µA. The 100, 250, or 400 µA currents caused an increase in supernatant 
activity, and a decrease in pellet activity. The 150 or 200 µA conditions caused an increase in 
both supernatant and pellet activity. All effects on either supernatant or pellet acid phosphatase 
activity were small (< 6 % different than control).  
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Figure 26. The effects of a 50 Hz, cathodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
 
 
 
 
Figure 27. The effects of a 50 Hz, cathodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
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activity resulted in measurable effects in both the supernatant and pellet activity that were 
significantly different from their controls. Six out of seven conditions had an effect on 
supernatant acid phosphatase activity, but no consistent trend between current and supernatant 
activity was observed (Figure 28). Five out of seven conditions had an effect on pellet acid 
phosphatase activity, but no consistent trend between current and pellet activity was observed 
(Figure 29). The current conditions that affected both the supernatant and pellet acid phosphatase 
activity were 100, 150, 200, or 400 µA. The 100 or 400 µA currents caused an increase in 
supernatant activity, and a decrease in pellet activity. The 150 µA condition caused an increase 
in both supernatant and pellet activity. The 200 µA condition caused a decrease in both 
supernatant and pellet activity. All effects on either supernatant or pellet acid phosphatase 
activity were small (< 7 % different than control). 
 
 
 
Figure 28. The effects of a 50 Hz, symmetric biphasic electric field at various current exposures 
on L. tarentolae secreted acid phosphatase are plotted as percent different from same time 
control 
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Figure 29. The effects of a 50 Hz, symmetric biphasic electric field at various current exposures 
on L. tarentolae cell pellet acid phosphatase are plotted as percent different from same time 
control 
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a decrease in supernatant activity, but an increase in pellet activity. All effects on either 
supernatant or pellet acid phosphatase activity were small (< 6 % different than control). 
 
 
 
Figure 30. The effects of a 50 Hz, anodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
 
 
 
 
Figure 31. The effects of a 50 Hz, anodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
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resulted in measurable effects in both the supernatant and pellet activity that were significantly 
different from their controls. Six out of seven conditions had an effect on supernatant acid 
phosphatase activity (Figure 32). An upward trend was observed between 100-300 µA. Under 
these conditions, more current application resulted in more acid phosphatase activity. Five out of 
seven conditions had a negative effect on pellet activity (Figure 33), suggesting a reciprocal 
trend between current and pellet activity was observed. The 250 or 500 µA conditions led to the 
largest decreases in pellet activity. The current conditions that affected both the supernatant and 
pellet acid phosphatase activity were 100, 150, 250, or 400 µA. All of these conditions caused an 
increase in supernatant activity, and a decrease in pellet activity. In general the effects of a 
10,000 Hz cathodic electric field were substantially larger than the effects of a 50 Hz cathodic 
electric field.  
 
 
 
Figure 32. The effects of a 10,000 Hz, cathodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
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Figure 33. The effects of a 10,000 Hz, cathodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
 
 
 
The application of a 10,000 Hz, symmetric biphasic electric field (7 different current 
conditions) to L. tarentolae supernatant or pellet followed by the assessment of acid phosphatase 
activity resulted in measurable effects in both the supernatant and pellet activity that were 
significantly different from their controls. Seven out of seven conditions had an effect on 
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The 400 µA condition caused a decrease in both supernatant and pellet activity. 
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Figure 34. The effects of a 10,000 Hz, symmetric biphasic electric field at various current 
exposures on L. tarentolae secreted acid phosphatase are plotted as percent different from same 
time control 
 
 
 
 
Figure 35. The effects of a 10,000 Hz, symmetric biphasic electric field at various current 
exposures on L. tarentolae cell pellet acid phosphatase are plotted as percent different from same 
time control 
 
 
 
The application of a 10,000 Hz, anodic electric field (7 different current conditions) to L. 
tarentolae supernatant or pellet followed by the assessment of acid phosphatase activity resulted 
3.84
3.18
4.42
1.71
1.50
-0.35
1.20
-1.00
0.00
1.00
2.00
3.00
4.00
5.00
P
er
ce
n
t 
D
if
fe
re
n
t
Supernatant Acid Phosphatase Percent Different than Control
100 µA
150 µA
200 µA
250 µA
300 µA
400 µA
500 µA
-9.17
7.30
-6.99
-4.97
-8.62
-5.72
-11.91
-15.00
-10.00
-5.00
0.00
5.00
10.00
P
er
ce
n
t 
D
if
fe
re
n
t
Pellet Acid Phosphatase Percent Different than Control
100 uA
150 uA
200 uA
250 uA
300 uA
400 uA
500 uA
51 
 
in measurable effects in both the supernatant and pellet activity that were significantly different 
from their controls. Seven out of seven conditions had an effect on supernatant acid phosphatase 
activity (Figure 36). Lower current applications resulted in less detectable SAP activity. Higher 
current applications resulted in more detectable SAP activity. There is an apparent threshold 
between 200 and 250 µA, where by more current results in more SAP activity. Six out of seven 
conditions had an effect on pellet acid phosphatase activity (Figure 37). There is an apparent 
trend between 150-400 µA where by applying less current leads to greater deactivation of the 
enzyme activity. The current conditions that affected both the supernatant and pellet acid 
phosphatase activity were 100, 150, 200, 300, 400 or 500 µA. The application of currents 
between 100-400 µA caused an increase in supernatant and a decrease in pellet activity. The 500 
µA condition caused an increase in both supernatant activity and in pellet activity.  
 
 
 
Figure 36. The effects of a 10,000 Hz, anodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
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Figure 37. The effects of a 10,000 Hz, anodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
 
 
 
Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pelet (Cells), Method 2 
In method 2, small volumes (0.5–2.0 mL) of L. tarentolae log phase cells are exposed to 
electric fields, followed by separation, suspension of pellets, and assaying of acid phosphatase 
activity. For data to be shown, the experimental condition must be significantly different from 
the non-treated control (p < 0.05) in a paired, two tailed t-test. The data are plotted as percent 
different from same time control (Equation 8). 
The application of a 50 Hz, cathodic electric field (7 different current conditions) to L. 
tarentolae whole cells followed by the separation and assessment of acid phosphatase activity 
resulted in measurable effects in both the supernatant and pellet activity that were significantly 
different from their controls. Five out of seven conditions had an effect on supernatant acid 
phosphatase activity (Figure 38), but there was no consistent trend between the current applied 
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phosphatase activity (Figure 39), but there was no consistent trend between the current applied 
and the effect on enzyme activity. The current conditions that affected both the supernatant and 
pellet acid phosphatase activity were 100, 300, 400 or 500 µA. The application of 100 µA caused 
an increase in supernatant and a decrease in pellet activity. The application of 300 or 500 µA 
caused a decrease in supernatant activity and an increase in pellet activity. The application of 400 
µA caused an increase in both supernatant and pellet activity.   
 
 
 
Figure 38. The effects of a 50 Hz, cathodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
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Figure 39. The effects of a 50 Hz, cathodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
 
 
 
The application of a 50 Hz, symmetric biphasic electric fields (7 different current 
conditions) to L. tarentolae whole cells followed by the separation and assessment of acid 
phosphatase activity resulted in measurable effects on only the pellet activity that were 
significantly different from their non-treated controls. Zero out of seven conditions had an effect 
on supernatant acid phosphatase activity (data not shown). Two out of seven conditions had an 
effect on pellet acid phosphatase activity (Figure 40), but there was no obvious trend between the 
current applied and the effect on enzyme activity. There were no current conditions that affected 
both the supernatant and pellet acid phosphatase activity. 
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Figure 40. The effects of a 50 Hz, symmetric biphasic electric field at various current exposures 
on L. tarentolae cell pellet acid phosphatase are plotted as percent different from same time 
control 
 
 
 
The application of a 50 Hz, anodic electric field (7 different current conditions) to L. 
tarentolae whole cells followed by the separation and assessment of acid phosphatase activity 
resulted in measurable effects in both the supernatant and pellet activity that was different from 
their non-treated controls. Two out of seven conditions had an effect on supernatant acid 
phosphatase activity (Figure 41), but there was no consistent trend between the current applied 
and the effect on enzyme activity. Five out of seven conditions had an effect on pellet acid 
phosphatase activity (Figure 42), but there was no consistent trend between the current applied 
and the effect on enzyme activity. The current condition that affected both the supernatant and 
pellet acid phosphatase activity was 400 µA, and this condition caused an increase in both the 
supernatant and pellet activity.  
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Figure 41. The effects of a 50 Hz, anodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
 
 
 
 
Figure 42. The effects of a 50 Hz, anodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
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The application of a 10,000 Hz, cathodic electric field (7 different current conditions) to 
L. tarentolae whole cells followed by the separation and assessment of acid phosphatase activity 
resulted in measurable effects in both the supernatant and pellet activity that were significantly 
different from their non-treated controls. Five out of seven conditions had an effect on 
supernatant acid phosphatase activity (Figure 43). An apparent trend exists between 300-500 µA 
where by more current leads to less enzyme activation. Five out of seven conditions had an effect 
on pellet acid phosphatase activity (Figure 44), but there was no consistent trend between the 
current applied and the effect on enzyme activity. The current conditions that affected both the 
supernatant and pellet acid phosphatase activity were 150, 300, or 400 µA. The application of 
150 µA resulted in decreased activity in both the supernatant and pellet. The 300 µA condition 
caused an increase in supernatant activity and in pellet activity. The 400 µA condition caused an 
increase in supernatant activity, but a decrease in pellet activity.  
 
 
 
Figure 43. The effects of a 10,000 Hz, cathodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
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Figure 44. The effects of a 10,000 Hz, cathodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
 
 
 
The application of a 10,000 Hz, symmetric biphasic electric field (7 different current 
conditions) to L. tarentolae whole cells followed by the separation and assessment of acid 
phosphatase activity resulted in measurable effects in both the supernatant and pellet activity that 
were different from their non-treated controls. Three out of seven conditions had an effect on 
supernatant acid phosphatase activity (Figure 45), but there was no consistent trend between the 
current applied and the effect on enzyme activity. Three out of seven conditions had an effect on 
pellet acid phosphatase activity (Figure 46), but there was no consistent trend between the 
current applied and the effect on enzyme activity. The current conditions that affected both the 
supernatant and pellet acid phosphatase activity were 300 or 500 µA. The application of 300 µA 
caused an increase in both the supernatant or pellet activity. The application of 500 µA caused a 
decrease in both the supernatant or pellet activity. 
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Figure 45. The effects of a 10,000 Hz, symmetric biphasic electric field at various current 
exposures on L. tarentolae secreted acid phosphatase are plotted as percent different from same 
time control 
 
 
 
 
Figure 46. The effects of a 10,000 Hz, symmetric biphasic electric field at various current 
exposures on L. tarentolae cell pellet acid phosphatase are plotted as percent different from same 
time control 
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 The application of a 10,000 Hz, anodic electric field (7 different current conditions) to L. 
tarentolae whole cells followed by the separation and assessment of acid phosphatase activity 
resulted in measurable effects in both the supernatant and pellet activity that was different from 
their non-treated controls. Four out of seven conditions had an effect on supernatant acid 
phosphatase activity (Figure 47), but there was no consistent trend between the current applied 
and the effect on enzyme activity. Five out of seven conditions had an effect on pellet acid 
phosphatase activity (Figure 48), but there was no consistent trend between the current applied 
and the effect on enzyme activity. The current conditions that affected both the supernatant and 
pellet acid phosphatase activity were 200, 250, 300 or 400 µA. The application of 200 µA caused 
a decrease in supernatant and an increase in pellet activity. The 250 or 400 µA conditions caused 
an increase in both the supernatant activity or pellet activity. The application of 300 µA resulted 
in decreased in both the supernatant or pellet activity.  
 
 
 
Figure 47. The effects of a 10,000 Hz, anodic electric field at various current exposures on L. 
tarentolae secreted acid phosphatase are plotted as percent different from same time control 
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Figure 48. The effects of a 10,000 Hz, anodic electric field at various current exposures on L. 
tarentolae cell pellet acid phosphatase are plotted as percent different from same time control 
 
 
 
Secreted Acid Phosphatase Enzyme Inhibition Assay (Following the Method of Baumhardt 
et al., 2015) 
Due to the complexity of the enzyme pool, the relative amounts of mono-, di-, tri-, tetra-, 
octa-, or deca-nuclear vanadium present in assay are not known. Standard speciation diagrams 
would indicate that under secreted acid phosphatase assay conditions, the main form of 
vanadium present is decavanadate (Figure 1, Baes, mesmer, 1976). When plotting (Figure 49) L. 
tarentolae secreted acid phosphatase enzyme activity (y-axis) incubated with V10 (red curve) or 
VO43- (blue curve) as a function of log [S]/[I] (x-axis), where [I] is either total moles of V10 or 
VO43-, there are three conditions where decavanadate or orthovanadate resulted in different 
effects from control and each other. These conditions are statistically significant (p < 0.05 in a 
paired, two-tailed t-test). These conditions occur when the log[S]/[I] ratio is equal to -0.5, 1.5, or 
2.0. Orthovanadate is a better inhibitor in two of these conditions (log[S]/[I] = -0.5 or 2.0), and 
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decavanadate is a better inhibitor in one condition (log [S]/[I] = 1.5). Plotting the data in this 
manner assumes that no vanadium speciation occurs. When plotting (Figure 50) L. tarentolae 
secreted acid phosphatase enzyme activity (y-axis) incubated with V10 (red curve) or VO43- (blue 
curve) as a function of log [S]/[I] (x-axis), where [I] is total moles of vanadium, there are six 
conditions where decavanadate or orthovanadate resulted in different effects from control and 
each other. These conditions are statistically significant (p < 0.05 in a paired, two-tailed t-test). 
These conditions occur when the log[S]/[I] ratio is equal to -1.5, -1.0, -0.5, 0.0, 0.5, or 1.0. 
Orthovanadate is a better inhibitor in all six of these conditions. Plotting the data in this manner 
attempts to compensate for the uncertainty associated with vanadium speciation and takes into 
account only the total moles of vanadium present. Under this assumption, orthovanadate is 
consistently better at inhibiting secreted acid phosphatase activity, on a mole of vanadium basis 
compared to decavanadate for an enzyme pool collected from L. tarentolae log phase cells.   
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Figure 49. L. tarentolae secreted acid phosphatase enzyme activity (Y-axis) when incubated with 
decavanadate (red curve) or orthovanadate (blue curve) plotted as a function of log [S]/[I] (X-
axis). [I] is either total moles of decavanadate or orthovanadate 
 
 
 
Figure 50. L. tarentolae secreted acid phosphatase enzyme activity (Y-axis) when incubated with 
decavanadate (red curve) or orthovanadate (blue curve) plotted as a function of log [S]/[I] (X-
axis). [I] is total moles of vanadium 
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Secreted Acid Phosphatase Enzyme Inhibition Assays with Pretreatment with Electric 
Fields Followed by Incubation with and without Orthovanadate  
(25 µM or LOG [S]/[I] = 1.19) 
The pretreatment of L. tarentolae log phase supernatant with a 50 Hz, cathodic electric 
field at various current amplitudes resulted in three conditions (150, 200, or 250 µA) that are 
different from control (Figure 51). These three conditions are statistically significant (p < 0.05 
for a paired, two tailed t-test). There is no consistent trend between current and secreted acid 
phosphatase inhibition greater than orthovanadate alone. The synergistic effect (more inhibition) 
of pretreatment with electric field followed by orthovanadate incubation is small. 
 
 
 
Figure 51. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 50 Hz, cathodic electric field at various 
current exposures followed by orthovanadate (25 µM) incubation compared to same time control 
(25 µM orthovanadate exposure only) are shown 
 
 
 
The pretreatment of L. tarentolae log phase supernatant with a 50 Hz, symmetric biphasic 
electric field at various current amplitudes resulted in three conditions (200, 300, or 500 µA) that 
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are significantly different from control (Figure 52). These three conditions are statistically 
significant (p < 0.05 for a paired, two tailed t-test). Under these conditions more current leads to 
greater inhibition compared to orthovanadate only incubation. The synergistic effect of 
pretreatment with electric field followed by orthovanadate incubation is, however, small. 
 
 
 
Figure 52. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 50 Hz, symmetric biphasic electric field 
at various current exposures followed by orthovanadate (25 µM) incubation compared to same 
time control (25 µM orthovanadate exposure only) are shown 
 
 
 
The pretreatment of L. tarentolae log phase supernatant with a 50 Hz, anodic electric 
field at various current amplitudes resulted in three conditions (150, 200, or 250 µA) that are 
different from control (Figure 53). These three conditions are statistically significant (p < 0.05 
for a paired, two tailed t-test). There is no apparent trend between current and inhibition. The 
synergistic effect of pretreatment with electric field followed by orthovanadate incubation is 
small. 
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Figure 53. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 50 Hz, anodic electric field at various 
current exposures followed by orthovanadate (25 µM) incubation compared to same time control 
(25 µM orthovanadate exposure only) are shown 
 
 
 
The pretreatment of L. tarentolae log phase supernatant with a 10,000 Hz, cathodic 
electric field at various current amplitudes resulted in five conditions (150, 250, 300, 400, or 500 
µA) that are different from control (Figure 54). These five conditions are statistically significant 
(p < 0.05 for a paired, two tailed t-test). There is no apparent trend between current and 
inhibition. The synergistic effect of pretreatment with electric field followed by orthovanadate 
incubation is small, but more substantial than with 50 Hz, cathodic treatment.  
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Figure 54. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 10,000 Hz, cathodic electric field at 
various current exposures followed by orthovanadate (25 µM) incubation compared to same time 
control (25 µM orthovanadate exposure only) are shown 
 
 
 
The pretreatment of L. tarentolae log phase supernatant with a 10,000 Hz, symmetric 
biphasic electric field at various current amplitudes resulted in five conditions (150, 200, 250, 
300, or 400 µA) that are different from control (Figure 55). These five conditions are statistically 
significant (p < 0.05 for a paired, two tailed t-test). There is no apparent trend between current 
and inhibition. The synergistic effect of pretreatment with electric field followed by 
orthovanadate incubation is small, and moderately smaller than shown by the 50 Hz, symmetric 
biphasic treatment. 
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Figure 55. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 10,000 Hz, symmetric biphasic electric 
field at various current exposures followed by orthovanadate (25 µM) incubation compared to 
same time control (25 µM orthovanadate exposure only) are shown 
 
 
 
The pretreatment of L. tarentolae log phase supernatant with a 10,000 Hz, anodic electric 
field at various current amplitudes resulted in six conditions (100, 150, 200, 250, 300, or 500 
µA) that are different from control (Figure 56). These six conditions are statistically significant 
(p < 0.05 for a paired, two tailed t-test). There is no apparent trend between current and 
inhibition. The synergistic effect of pretreatment with electric field followed by orthovanadate 
incubation is small, and in the range observed with the 50 Hz, anodic treatment. 
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Figure 56. The effects, plotted as percent different from control, of pretreating the log phase L. 
tarentolae secreted acid phosphatase enzyme pool with 10,000 Hz, anodic electric field at 
various current exposures followed by orthovanadate (25 µM) incubation compared to same time 
control (25 µM orthovanadate exposure only) are shown 
 
 
 
Secreted Acid Phosphatase Kinetics Assay with and without the Preincubation with a 
Glycosidase, Followed by Pretreatment with and without Electric Fields 
The pretreatment of log phase L. tarentolae enzyme pool with the glycosidase, PNGase F, 
resulted in a 5.00 % decrease in the kM value of enzyme 1 compared to control, but no 
statistically significant difference in the VMAX value of enzyme 1 compared to control (Table 4). 
The pretreatment of log phase L. tarentolae enzyme pool with PNGase F resulted in a 36.49 % 
decrease in the kM value of enzyme 2 compared to control, but no statistically significant 
difference in the VMAX value of enzyme 2 compared to control (Table 5). The pretreatment of log 
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to control, and a 12. 57 increase in the VMAX value of enzyme 1 compared to control. The 
pretreatment of log phase L. tarentolae enzyme pool with PNGase F followed by the application 
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of 10,000 Hz, 100 µA, anodic electric field resulted in no changes in either kM or VMAX value of 
enzyme 2 that were statistically different compared to control.   
 
 
Conditions kM (µM) 
VMAX  
(µM/23 Hr) 
kM Percent 
different versus 
control 
VMAX Percent 
different versus 
control 
24 Hour 
incubation with 
PNGase F 
0.114 ± 0.030 55.866 ± 1.616 -5.00 
Not statistically 
different from 
control 
24 Hour 
incubation with 
PNGase F 
followed by 30 
min exposure to 
10,000 Hz, 100 
µA, anodic 
electric field 
0.130 ± 0.011 62.500 ± 1.937 -8.33 12.57 
Table 4. Enzyme 1 kinetic parameters kM and VMAX under different conditions compared to 
control. Negative percentages indicate a decrease in value compared to control. Positive 
percentages indicate an increase in value compared to control 
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Conditions kM (µM) 
VMAX 
(µM/23 Hr) 
kM Percent 
different versus 
control 
VMAX Percent 
different versus 
control 
24 Hour 
incubation with 
PNGase F 
1.480 E-04 ± 
0.033 E-04 
 
30.647 ± 0.688  -34.69 
Not statistically 
different from 
control 
24 Hour 
incubation with 
PNGase F 
followed by 30 
min exposure to 
10,000 Hz, 100 
µA, anodic 
electric field 
4.926 E-04 ± 
2.440 E-04 
33.818 ± 1.891  
Not statistically 
different from 
control 
Not statistically 
different from 
control 
Table 5. Enzyme 2 kinetic parameters kM and VMAX under different conditions compared to 
control. Negative percentages indicate a decrease in value compared to control. Positive 
percentages indicate an increase in value compared to control 
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CHAPTER IV 
CONCLUSIONS AND FUTURE WORK 
Cell Culture and Microscopy of L. tarentolae and Assessment of Cell Viability by the MTT 
Assay 
Using L. tarentolae promastigotes as a model system to probe potential Leishmania 
therapeutics continues to prove itself useful, especially in the context of this work. The capacity 
for these cells to be easily grown, assessed by multiple metrics (MTT assay and microscopy), 
and their predictable behavior make them a valuable tool as a model system.  
Secreted Acid or Alkaline Phosphatase Enzyme Assay 
Secreted acid phosphatase activity for L. tarentolae supernatant is detectable on all eight 
days of a typical L. tarentolae growth curve. Because the log phase is likely the most relevant 
phase to the Leishmania infection cycle, log phase whole cells or cell supernatant should be used 
in all future studies for this work. Secreted alkaline phosphatase activity is not detectable on any 
of the eight days of the L. tarentolae growth curve. Therefore, secreted alkaline phosphatase 
activity should not be assayed in any future studies of this work.  
Kinetic Enzyme Assay 
Supernatant enzyme source collected from L. tarentolae log phase cells gives an apparent 
typical Michaelis-Menten type response to increasing substrate concentrations. However, the 
Lineweaver-Burk linear transformation of the V versus S curve of the L. tarentolae log phase 
supernatant produced two straight lines (Figures 15, 16, and 17). Thus, two enzymes with 
different kM or VMAX values are detectable in the L. tarentolae log phase cell supernatant 
(Figures 18 and 19, and Tables 2 and 3) using this kinetic approach. These kinetic data correlate 
with the gene data indicating two separate enzymes as reported by Shakariana et al., 1997. 
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Enzyme 1 has a larger kM and larger VMAX (Table 2) than enzyme 2. Enzyme 2 has a smaller kM 
and smaller VMAX (Table 3) than enzyme 1. Enzyme 1 binds substrate less effectively than 
enzyme 2, but enzyme 1 makes product at a larger velocity than enzyme 2. The capacity of 
enzyme 1 to be detected on all eight days of the L. tarentolae growth curve suggests this enzyme 
may play a role beyond that of aiding in survival of the parasite in the sand fly or aiding in 
human infectivity. The inability for enzyme 2 to be detected on days one and two  of the L. 
tarentolae growth curve, followed by its lower VMAX value on days three to six, then a large 
apparent increase in VMAX as the culture appears to enter the senescence phase (Figure 19, Day 
7) suggests that enzyme 2 may be stored and released for a specific function. This interpretation 
assumes VMAX is only increasing because the concentration of enzyme 2 is increasing, and that 
VMAX is equal to k2[Etotal] for a Michaelis-Menten type enzyme.  
Testing the Acute Effects of Electric Fields on L. tarentolae Growth Curves and Microscopy 
L. tarentolae MTT response was unaffected by treatment with any of the tested electric 
fields. However, the cells do appear to respond to electric fields since L. tarentolae cell clumping 
is differentially affected by electric field frequency, polarity, and current. As the electric field 
frequency increases, L. tarentolae cell clumping increases.  Effect of polarity is such that the 
application of any electric field causes aggregation of L. tarentolae underneath the electrode, 
with cell population density decreasing as a function of distance away from the electrode. 
Furthermore, the application of anodic electric fields causes the cells not only to aggregate, but 
also to clump. We interpret this clumping as a stress response from L. tarentolae. As current 
amplitude increases, L. tarentolae cell clumping increases. The interpretation of a treatment 
causing cell clumping is that said treatment is stressing the cells. In cell clumps, L. tarentolae 
may exhibit a behavior identified as quorum sensing. During quorum sensing, cells restrict the 
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expression of specific genes to the high cell densities at which the resulting phenotypes will be 
most beneficial to survival (Miller, Bassler, 2001). Therefore, the conditions of electric fields 
could be optimized such that maximum cell aggregation occurs in one area, thus making 
effective dosing of a topical therapeutic more easily accomplished.    
Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pellet (Cells), Method 1 
Method 1 was used to investigate eighty-four different experimental conditions and 
Figure 57 is a summary. Seventy-two of the eighty-four experimental conditions were different 
than control and statistically significant (p < 0.05 for a paired, two tailed t-test). Thirty-eight of 
the forty-two conditions tested with the supernatant enzymes were statistically different from 
controls (p < 0.05 for a paired, two tailed t-test). Thirty-four of the forty-two conditions tested on 
the cell pellets were statistically different from controls (p < 0.05 for a paired, two tailed t-test). 
Thirty of the eighty-four tested conditions affected both the supernatant and the cell pellet acid 
phosphatase activity. Twenty-one of the thirty conditions caused an increase in supernatant 
activity and a decrease in pellet activity. Five of the thirty conditions increased both supernatant 
and pellet activity. Two of the thirty conditions decreased the supernatant or pellet activity. Two 
of the thirty conditions decreased supernatant activity or increased pellet activity.  
Thirty-four of the forty-two 50 Hz conditions tested were statistically significant (p < 
0.05 for a paired, two tailed t-test). Eighteen of the thirty-four significant results were from 
applying electric fields to L. tarentolae log phase cell supernatant. The magnitude of the average 
effect from a 50 Hz cathodic electric field is 2.10 % different from control (2.35 % activation, 
0.86 % inhibition). The magnitude of the average effect from a 50 Hz symmetric biphasic 
electric field is 2.59 % different from control (2.00 % activation, 3.19 % inhibition). The 
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magnitude of the average effect from a 50 Hz anodic electric field is 0.56 % different from 
control (0.52 % activation, 0.57 % inhibition). Sixteen of the thirty-four significant results were 
from applying electric fields to L. tarentolae log phase cell pellets. The magnitude of the average 
effect from a 50 Hz cathodic electric field is 1.72 % different from control (1.51 % activation, 
1.93 % inhibition). The magnitude of the average effect from a 50 Hz symmetric biphasic 
electric field is 3.91 % different from control (4.47 % activation, 3.54 % inhibition). The 
magnitude of the average effect from a 50 Hz anodic electric field is 4.38 % different from 
control (5.08 % activation, 3.33 % inhibition). Within the 50 Hz frequency, the largest activation 
effect on average is seen from the application of 50 Hz anodic electric fields to L. tarentolae cell 
pellets. The greatest average inhibition caused by 50 Hz is the application of 50 Hz symmetric 
biphasic electric fields to L. tarentolae log phase cell pellets.  
Thirty-eight of the forty-two 10,000 Hz conditions tested were statistically significant (p 
< 0.05 for a paired, two tailed t-test). Twenty of the thirty-eight significant results were from 
applying electric fields to L. tarentolae log phase cell supernatant. The magnitude of the average 
effect from a 10,000 Hz cathodic electric field is 12.31 % different from control (12.31 % 
activation, 0.00 % inhibition). The magnitude of the average effect from a 10,000 Hz symmetric 
biphasic electric field is 2.31 % different from control (2.64 % activation, 0.35 % inhibition). 
The magnitude of the average effect from a 10,000 Hz anodic electric field is 14.27 % different 
from control (14.27 % activation, 0.00 % inhibition). Eighteen of the thirty-eight significant 
results were from applying electric fields to L. tarentolae log phase cell pellets. The magnitude 
of the average effect from a 10,000 Hz cathodic electric field is 16.56 % different from control 
(0.00 % activation, 16.56 % inhibition). The magnitude of the average effect from a 10,000 Hz 
symmetric biphasic electric field is 7.81 % different from control (7.30 % activation, 7.90 % 
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inhibition). The magnitude of the average effect from a 10,000 Hz anodic electric field is 4.28 % 
different from control (4.90 % activation, 4.16 % inhibition). Within the 10,000 Hz frequency, 
the largest activation effect on average is seen from the application of 10,000 Hz cathodic 
electric fields to L. tarentolae cell pellets. The greatest average activation caused by 10,000 Hz is 
the application of 10,000 Hz anodic electric fields to L. tarentolae log phase cell supernatant. 
The greatest average inhibition caused by 10,000 Hz is the application of 10,000 Hz cathodic 
electric fields to L. tarentolae log phase cell pellets. 
Testing the Effects of Electric Fields on L. tarentolae Acid Phosphatase Activity in 
Supernatant or Pellet (Cells), Method 2 
Method 2 was used to investigate eighty-four different experimental conditions and 
Figure 58 is a summary. Forty-five of the eighty-four experimental conditions were different 
than control and statistically significant (p < 0.05 for a paired, two tailed t-test). Nineteen of the 
forty-two conditions tested with the supernatant enzymes were statistically different from 
controls (p < 0.05 for a paired, two tailed t-test). Twenty-six of the forty-two conditions tested on 
the pellets were statistically different from controls (p < 0.05 for a paired, two tailed t-test). 
Fourteen of the eighty-four tested conditions affected both the supernatant and the pellet acid 
phosphatase activity. Two of the fourteen conditions caused an increase in supernatant activity 
and a decrease in pellet activity. Six of the fourteen conditions increased both supernatant and 
pellet activity. Three of the fourteen conditions decreased both the supernatant and pellet 
activity. Three of the fourteen conditions decreased supernatant activity or increased pellet 
activity.  
Twenty of the forty-two 50 Hz conditions tested were statistically significant (p < 0.05 
for a paired, two tailed t-test). Seven of the twenty significant results were from applying electric 
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fields to L. tarentolae log phase cell supernatant. The magnitude of the average effect from a 50 
Hz cathodic electric field is 2.50 % different from control (3.04 % activation, 1.70 % inhibition). 
The magnitude of the average effect from a 50 Hz symmetric biphasic electric field cannot be 
discussed due to these data not being statistically different from control. The magnitude of the 
average effect from a 50 Hz anodic electric field is 2.67 % different from control (2.67 % 
activation, 0.00 % inhibition). Thirteen of the twenty significant results were from applying 
electric fields to L. tarentolae log phase cell pellets. The magnitude of the average effect from a 
50 Hz cathodic electric field is 3.11 % different from control (3.38 % activation, 2.97 % 
inhibition). The magnitude of the average effect from a 50 Hz symmetric biphasic electric field is 
19.34 % different from control (36.2 % activation, 2.43 % inhibition). The magnitude of the 
average effect from a 50 Hz anodic electric field is 2.43 % different from control (1.91 % 
activation, 3.21 % inhibition). Within the 50 Hz frequency, the largest effect on average is seen 
from the application of 50 Hz symmetric biphasic electric fields to L. tarentolae cell pellets. The 
greatest average activation caused by 50 Hz is the application of 50 Hz cathodic electric fields to 
L. tarentolae log phase cell supernatant. The greatest average inhibition caused by 50 Hz is the 
application of 50 Hz symmetric biphasic electric fields to L. tarentolae log phase cell pellets.  
Twenty-five of the forty-two 10,000 Hz conditions tested were statistically significant (p 
< 0.05 for a paired, two tailed t-test). Twelve of the twenty-five significant results were from 
applying electric fields to L. tarentolae log phase cell supernatant. The magnitude of the average 
effect from a 10,000 Hz cathodic electric field is 1.17 % different from control (1.49 % 
activation, 0.71 % inhibition). The magnitude of the average effect from a 10,000 Hz symmetric 
biphasic electric field is 0.88 % different from control (0.69 % activation, 1.26 % inhibition). 
The magnitude of the average effect from a 10,000 Hz anodic electric field is 2.25 % different 
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from control (1.51 % activation, 2.98 % inhibition). Thirteen of the twenty-five significant 
results were from applying electric fields to L. tarentolae log phase cell pellets. The magnitude 
of the average effect from a 10,000 Hz cathodic electric field is 4.48 % different from control 
(7.31 % activation, 3.07 % inhibition). The magnitude of the average effect from a 10,000 Hz 
symmetric biphasic electric field is 9.91 % different from control (8.75 % activation, 12.22 % 
inhibition). The magnitude of the average effect from a 10,000 Hz anodic electric field is 5.13 % 
different from control (6.00 % activation, 3.35 % inhibition). Within the 10,000 Hz frequency, 
the largest effect on average is seen from the application of 10,000 Hz symmetric biphasic 
electric fields to L. tarentolae cell pellets. The greatest average activation caused by 10,000 Hz is 
the application of 10,000 Hz symmetric biphasic electric fields to L. tarentolae log phase cell 
supernatant. The greatest average inhibition caused by 10,000 Hz is the application of 10,000 Hz 
symmetric biphasic electric fields to L. tarentolae log phase cell pellets. This apparent 
discrepancy can be explained by understanding that different currents within a single frequency 
and polarity had different effects on acid phosphatase enzyme activity.  
Comparing the Effectiveness of Method 1 to Method 2 
When comparing the effectiveness of method 1 (separating supernatant from pellet then 
applying electric fields directly to enzyme pools) to method 2 (applying electric fields to whole 
cells followed by separation of supernatant from pellet), the number of total experiments that 
produced statistically different enzyme activity compared to control are seventy-two (method 1) 
compared to forty-five (method 2). As shown in Figures 57 and 58, the total number of 
statistically significant supernatant experiments is thirty-eight (method 1) compared to nineteen 
(method 2). The total number of statistically significant pellet experiments is thirty-four (method 
1) compared to twenty-six (method 2). Comparing the average effect from a 50 Hz waveform on 
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L. tarentolae cell supernatant acid phosphatase activity, utilizing either method 1 or method 2, 
method 2 (2.59 % different than control) produced a larger effect, on average, than method 1 
(1.75 % different than control). Comparing the activating effect from a 50 Hz waveform on L. 
tarentolae cell supernatant acid phosphatase activity, utilizing either method 1 or method 2, 
method 2 (2.86 % different than control) is more effective than method 1 (1.62 % different than 
control). Comparing the inhibition effect from a 50 Hz waveform on L. tarentolae cell 
supernatant acid phosphatase activity, utilizing either method 1 or method 2, method 1 (1.54 % 
different than control) is more effective than method 2 (0.85 % different than control). Thus, 
while the total number of statistically significant results is larger when using method 1, the 
overall magnitude of the effect, or the activation effect, of the application of 50 Hz electric fields 
is larger on L. tarentolae cell supernatant when using method 2. The magnitude of the inhibition 
effect on L. tarentolae cell supernatant caused by the application of 50 Hz magnetic fields is 
largest when using method 1.    
Comparing the average effect from a 10,000 Hz waveform on L. tarentolae cell 
supernatant acid phosphatase activity, utilizing either method 1 or method 2, method 1 (9.63 % 
different than control) is more effective than method 2 (1.43 % different than control). 
Comparing the activating effect from a 10,000 Hz waveform on L. tarentolae cell supernatant 
acid phosphatase activity, utilizing either method 1 or method 2, method 1 (9.74 % different than 
control) is more effective than method 2 (1.23 % different than control). Comparing the 
inhibition effect from a 10,000 Hz waveform on L. tarentolae cell supernatant acid phosphatase 
activity, utilizing either method 1 or method 2, method 2 (1.65 % different than control) is more 
effective than method 1 (0.12 % different than control). Thus, the total number of statistically 
significant results is larger when using method 1, and the overall magnitude of the effect, or the 
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activation effect, of the application of 10,000 Hz electric fields is larger on L. tarentolae cell 
supernatant when using method 1. The magnitude of the inhibition effect on L. tarentolae cell 
supernatant caused by the application of 10,000 Hz magnetic fields is largest when using  
method 2. 
Comparing the average effect from a 50 Hz waveform on L. tarentolae cell pellet acid 
phosphatase activity, utilizing either method 1 or method 2, method 2 (8.29 % different than 
control) is more effective than method 1 (3.34 % different than control). Comparing the 
activating effect from a 50 Hz waveform on L. tarentolae cell pellet acid phosphatase activity, 
utilizing either method 1 or method 2, method 2 (13.84 % different than control) is more 
effective than method 1 (3.69 % different than control). Comparing the inhibition effect from a 
50 Hz waveform on L. tarentolae cell supernatant acid phosphatase activity, utilizing either 
method 1 or method 2, method 1 (2.93 % different than control) is more effective than method 2 
(2.87 % different than control). Thus, while the total number of statistically significant results is 
larger when using method 1, the overall magnitude of the effect, or the activation effect, of the 
application of 10,000 Hz electric fields is larger on L. tarentolae cell pellets when using method 
2. The magnitude of the inhibition effect on L. tarentolae cell pellets caused by the application of 
50 Hz magnetic fields is largest when using method 1. 
Comparing the average effect from a 10,000 Hz waveform on L. tarentolae cell pellet 
acid phosphatase activity, utilizing either method 1 or method 2, method 1 (9.55 % different than 
control) is more effective than method 2 (6.51 % different than control). Comparing the 
activating effect from a 10,000 Hz waveform on L. tarentolae cell pellet acid phosphatase 
activity, utilizing either method 1 or method 2, method 2 (7.35 % different than control) is more 
effective than method 1 (4.07 % different than control). Comparing the inhibition effect from a 
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10,000 Hz waveform on L. tarentolae cell supernatant acid phosphatase activity, utilizing either 
method 1 or method 2, method 1 (9.54 % different than control) is more effective than method 2 
(6.21 % different than control). Thus, both the total number of statistically significant results is 
larger when using method 1, and the overall magnitude, or inhibition effect, of the application of 
10,000 Hz electric fields is larger on L. tarentolae cell pellets when using method 1. The 
magnitude of the activation effect on L. tarentolae cell pellets caused by the application of 
10,000 Hz magnetic fields is largest when using method 2.  
 
 
 
Figure 57. A summary of the results from method 1 
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Figure 58. A summary of the results from method 2 
 
 
 
Secreted Acid Phosphatase Enzyme Inhibition Assay (Following the Method of Baumhardt 
et al., 2015) 
Using Baumhardt et al., 2015 as model system, it is clear that when comparing the 
inhibitory effects of decavanadate to orthovanadate on L. tarentolae log phase supernatant acid 
phosphatase activity, orthovanadate is a better inhibitor than decavanadate on a mole of total 
vanadium basis (Figure 50). These data correlate with the x-ray diffraction data in the studies 
reviewed by McLauchlan et al. (2015). Therefore, orthovanadate was used as an inhibitor at the 
log[S]/[I] ratio = 1.19 in most of this thesis work. This ratio is selected because it inhibits acid 
phosphatase activity but does not completely shut down the enzyme. Thus, any potential 
synergistic effect caused by electric field treatment followed by orthovanadate exposure can be 
observed.  
 
83 
 
Secreted Acid Phosphatase Enzyme Inhibition Assays with Pretreatment with Electric 
Fields Followed by Incubation with and without Orthovanadate (25 µM) 
Pretreatment of L. tarentolae log phase supernatant with 50 Hz electric fields followed by 
incubation with competitive inhibitor orthovanadate (25 µM, log [S]/[I] = 1.19) resulted in nine 
out of the twenty-one tested conditions being statistically different (p < 0.05 for a paired, two 
tailed t-test) than control (incubation with orthovanadate, 25 µM, only). The average magnitude 
of the 50 Hz cathodic electric field is 1.98 % different from control (3.08 % activation, 1.43 % 
inhibition). The average magnitude of the 50 Hz symmetric biphasic electric field is 3.21 % 
different from control (0.00 % activation, 3.21 % inhibition). The average magnitude of the 50 
Hz anodic electric field is 3.04 % different from control (2.88 % activation, 3.36 % inhibition). 
Pretreatment of L. tarentolae log phase supernatant with 10,000 Hz electric fields 
followed by incubation with competitive inhibitor orthovanadate (25 µM) resulted in seventeen 
out of the twenty-one tested conditions being statistically different (p < 0.05 for a paired, two 
tailed t-test) than control (incubation with orthovanadate, 25 µM, only). The average magnitude 
of the 10,000 Hz cathodic electric field is 5.85 % different from control (6.81 % activation, 5.22 
% inhibition). The average magnitude of the 10,000 Hz symmetric biphasic electric field is 1.76 
% different from control (2.05 % activation, 1.32 % inhibition). The average magnitude of the 
10,000 Hz anodic electric field is 3.46 % different from control (3.74 % activation, 2.91 % 
inhibition). 
The total average effect from the application of electric fields to L. tarentolae log phase 
cell supernatant is larger for 10,000 Hz electric fields (3.69 %) compared to 50 Hz electric fields 
(2.74 %). The average activation from the application of electric fields to L. tarentolae log phase 
cell supernatant is larger for 10,000 Hz electric fields (4.20 %) compared to 50 Hz electric fields 
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(1.99 %). The average deactivation from the application of electric fields to L. tarentolae log 
phase cell supernatant is larger for 10,000 Hz electric fields (3.15 %) compared to 50 Hz electric 
fields (2.67 %). Therefore, the greatest antagonistic effects that occur from pretreatment by 
electric fields followed by orthovanadate incubation are with 10,000 Hz electric fields. The 
largest synergistic effect between electric fields and orthovanadate incubation also comes from 
10,000 Hz electric fields. This apparent discrepancy can be explained by the fact that different 
current amplitudes or electric field polarities within the 10,000 Hz frequency have different 
effects, some activate secreted acid phosphatase activity (antagonistic effect with orthovanadate 
inhibitor), some inhibit secreted acid phosphatase activity (synergistic effect with orthovanadate 
inhibitor).  
Secreted Acid Phosphatase Kinetic Assay with and without the Preincubation with a 
Glycosidase, Followed by Pretreatment with and without Electric Fields 
 The importance of carbohydrate attachment to L. tarentolae SAP1 or SAP2 becomes 
apparent when the enzyme source was incubated with PNGase F. The capacity of the PNGase F 
incubation with L. tarentolae enzyme pool to alter kinetic parameters of enzyme 1 and enzyme 2 
indicates that the N-linked carbohydrates of enzyme 1 and enzyme 2 are of importance to these 
enzymes to bind substrate (kM values of enzyme 1 and enzyme 2 are affected by PNGase F 
incubation). Furthermore, enzyme 1 is more sensitive to the application of a 10,000 Hz, 100 µA, 
anodic electric field after preincubation of the L. tarentolae enzyme pool with PNGase F. These 
data further support the idea that there are two isoforms of SAP secreted by L. tarentolae into the 
culture medium, and that their responses to PNGase F incubation and electric field application 
are different and thus may have different roles in successful infections.  
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Final Global Conclusions and Recommendations for Future Work 
 L. tarentolae secrete two detectable acid phosphatases into the culture medium, enzyme 
1 and enzyme 2. These two isoforms have different kinetic parameters, kM and VMAX, such that 
enzyme 1 binds substrate less tightly than enzyme 2, but enzyme 1 also produces product more 
quickly than does enzyme 2. Furthermore, L. tarentolae has utility as a model system for 
assessing the effects applying electric fields have on cell viability and enzyme activity of enzyme 
1 and enzyme 2. The application of electric fields does not affect cell viability of L. tarentolae, 
but does have a large effect on L. tarentolae cell clumping. Increasing frequency, or current, or 
applying anodic electric fields leads to increased L. tarentolae cell clumping compared to 
control. Applying electric fields to L. tarentolae cell supernatant (method 1) produced more 
statistically significant results than did applying electric fields to whole cells followed by 
separation and collection of supernatant (method 2). The application of 10,000 Hz electric fields 
produced larger effects on L. tarentolae cell supernatant on average than did the application of 
50 Hz electric fields (9.63 % different from control vs. 1.75 % different from control). The 
application of 10,000 Hz electric fields produced larger activation effects on L. tarentolae cell 
supernatant than did the application of 50 Hz electric fields (9.74 % different from control vs. 
2.86 % different from control). The application of 10,000 Hz electric fields produced larger 
inhibition effects on L. tarentolae cell supernatant than did the application of 50 Hz electric 
fields (1.65 % different from control vs. 1.54 % different from control). Overall, electric fields 
had the effect of increasing SAP activity from L. tarentolae log or stationary phase enzyme 
pools. The method of Baumhardt et al. proved useful for determining which of the two tested 
inhibitors were better on a mole of vanadium basis, orthovanadate or decavanadate. By this 
method, orthovanadate was a better inhibitor of L. tarentolae SAP activity than was 
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decavanadate. Following through with this result, the application of electric fields to L. 
tarentolae followed by incubation with orthovanadate (25 µM) did not lead to a consistent 
synergistic effect on L. tarentolae SAP activity. Incubation of L. tarentolae stationary phase SAP 
enzyme pool with PNGase F did lead to changes in kM values of both enzyme 1 and enzyme 2. 
The incubation of L. tarentolae stationary phase SAP enzyme pool followed by the application 
of 10,000 Hz, 100 µA, anodic electric field had an effect on kM and VMAX values of enzyme 1, 
but no effect on enzyme 2.  
Based on these global conclusions this author recommends the following when working 
under the conditions of the methods presented here. To investigate SAP activity from L. tarentolae, 
collection of the supernatant from the log phase or stationary phase of the L. tarentolae growth 
curve will result in the greatest amount of activity from enzyme 1. To investigate enzyme 2, 
collection of the L. tarentolae stationary or senescence phase supernatant will result in the greatest 
activity from enzyme 2. To investigate both enzymes, collection of L. tarentolae log or stationary 
phase supernatant will suffice, as both enzymes are present and detectable during these phases of 
the L. tarentolae growth curve. To further investigate the effect of electric field on L. tarentolae 
cell aggregation and/or cell clumping, use larger frequencies (10,000 Hz), larger currents (500 
µA), and anodic polarities for thirty minute exposures. These conditions will result in a large 
clumping effect, but will also not lead to L. tarentolae cell death due to electric field exposure. To 
further investigate, or to begin probing the mechanism, of how the application of electric fields 
modulates log or stationary phase L. tarentolae SAP activity, the 10,000 Hz frequency is most 
useful as it has produced the greatest measurable effects thus far. To further investigate any 
potential synergism between the application of electric fields followed by incubation with a 
competitive inhibitor, the method of Baumhardt et al., with experiments performed under the same 
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assay conditions as electric field experiments, proves very useful. This method allows the 
determination of which of any potential competitive inhibitor is most effective at enzyme 
inhibition on a stoichiometric basis of inhibitor to substrate (log[S]/[I]). This work suggests that 
the application of electric fields followed by incubation with orthovanadate does not produce a 
large synergistic effect. The following method is recommended for future work on synergism 
between orthovanadate and electric fields for the purpose of inhibiting L. tarentolae SAP activity. 
A master pool of assay buffer, enzyme source and orthovanadate should be produced such that 
buffer occupies 55.56 % of the volume of the master pool, enzyme source occupies 33.33 % of the 
volume of the master pool, orthovanadate (25 µM) is added to the master pool, and aliquots (2.00 
mL) of this master pool are then exposed to electric fields. After electric field exposure, aliquots 
of the master pool will be added to 1.5 mL polypropylene tubes, and PNPP will be added (100 µL 
of 1.347 mM) to give a final assay volume of 0.9 mL. Assays will be stopped with the addition of 
NaOH (0.1 mL, 10 M), and product will be measured by spectroscopy (A405 nm). Results from 
this thesis do now suggest that the therapeutic response reported by Hejazi et al. (1972), using 
electrical treatment of mice, may involve the direct as well as indirect effects of electricity on the 
activity of secreted acid phosphatases. Clearly more work is needed to sort out the full mechanism 
of action of electric fields on Leishmania secreted acid phosphatases.   
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APPENDIX A 
THE INDIVIDUAL LINEWEAVER-BURK PLOTS AND DATA POINTS 
CORRESPONDING TO THE TEXT (TABLE 2, FIGURE 18, 
 TABLE 3, AND FIGURE 19). 
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Day 1         
Enzyme 1      
KM (µM):  
1.36E03±1.3E02    
  
VMAX (µM/23 Hr):  
54.9±1.1E-01    
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-nitrophenyl standard deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-nitrophenol] 
(1/µM/23 Hr) 
150 5.56 0.180 6.67E-03 0.00E+00 
200 7.22 0.138 5.00E-03 6.31E-03 
250 8.33 0.120 4.00E-03 4.62E-03 
300 9.44 0.106 3.33E-03 0.00E+00 
350 11.1 9.00E-02 2.86E-03 4.50E-03 
400 12.2 8.18E-02 2.50E-03 1.26E-17 
450 13.3 7.50E-02 2.22E-03 0.00E+00 
500 14.4 6.92E-02 2.00E-03 1.52E-03 
550 15.6 6.43E-02 1.82E-03 1.31E-03 
1.00E+03 23.3 4.29E-02 1.00E-03 5.84E-04 
2.00E+03 36.1 2.77E-02 5.00E-04 4.89E-04 
4.00E+03 50.6 1.98E-02 2.50E-04 2.51E-04 
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y = 22.3x + 0.0175
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Day 2         
Enzyme 1      
KM (µM): 
1.27E03±1.0E02    
  
VMAX (µM/23 Hr): 
57.1±1.0E-01     
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/ µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 6.11 0.164 6.67E-03 0.00E+00 
200 7.78 0.129 5.00E-03 5.18E-03 
250 9.44 0.106 4.00E-03 0.00E+00 
300 10.6 9.47E-02 3.33E-03 1.69E-17 
350 11.7 8.57E-02 2.86E-03 2.32E-03 
400 13.3 7.50E-02 2.50E-03 3.13E-03 
450 15.0 6.67E-02 2.22E-03 1.44E-03 
500 16.1 6.21E-02 2.00E-03 1.25E-03 
1.00E+03 25.0 4.00E-02 1.00E-03 1.39E-03 
2.00E+03 37.2 2.69E-02 5.00E-04 4.61E-04 
4.00E+03 48.9 2.05E-02 2.50E-04 1.34E-04 
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y = 17.5x + 0.0158
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Day 3         
Enzyme 1      
KM (µM): 
1.11E03±9.1E01    
  
VMAX (µM/23 Hr): 
63.3±9.0E-01       
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 7.78 0.129 6.67E-03 0.00E+00 
200 9.44 0.106 5.00E-03 1.00E-03 
250 11.7 8.57E-02 4.00E-03 1.62E-03 
300 13.3 7.50E-02 3.33E-03 8.47E-18 
350 14.4 6.92E-02 2.86E-03 5.95E-04 
400 16.7 6.00E-02 2.50E-03 4.54E-04 
450 17.8 5.63E-02 2.22E-03 1.11E-04 
500 20.0 5.00E-02 2.00E-03 2.00E-04 
550 21.1 4.74E-02 1.82E-03 0.00E+00 
1.00E+03 30.6 3.27E-02 1.00E-03 6.00E-04 
2.00E+03 43.3 2.31E-02 5.00E-04 8.00E-04 
4.00E+03 53.9 1.86E-02 2.50E-04 1.00E-04 
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y = 1.60x + 0.709
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Day 3         
Enzyme 2      
KM (µM):  
2.26±7.20E-02    
  
VMAX (µM/23 Hr): 
1.40±2.00E-01     
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
2.62 0.722 1.38 3.82E-01 2.73E-02 
2.99 0.889 1.13 3.34E-01 1.78E-02 
3.37 0.722 1.38 2.97E-01 6.84E-03 
3.74 0.944 1.06 2.67E-01 1.03E-02 
4.12 0.833 1.20 2.43E-01 9.72E-03 
4.49 1.22 0.818 2.23E-01 5.95E-03 
6.00 1.28 0.783 1.67E-01 1.64E-02 
8.83 0.778 1.29 1.13E-01 7.18E-03 
1.20E+01 1.06 0.947 8.33E-02 1.65E-02 
1.40E+01 1.67 0.600 7.14E-02 1.39E-02 
1.80E+01 1.28 0.783 5.56E-02 3.74E-03 
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Day 4         
Enzyme 1      
KM (µM): 
1.27E03±9.0E01    
  
VMAX (µM/23 Hr): 
69.4±6.1E-01       
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
250 11.7 8.57E-02 4.00E-03 4.60E-03 
300 13.3 7.50E-02 3.33E-03 7.36E-03 
350 14.4 6.92E-02 2.86E-03 2.81E-03 
400 16.7 6.00E-02 2.50E-03 2.71E-03 
450 17.8 5.62E-02 2.22E-03 1.19E-03 
500 20.0 5.00E-02 2.00E-03 9.56E-04 
550 21.1 4.74E-02 1.82E-03 0.00E+00 
1.00E+03 30.6 3.27E-02 1.00E-03 0.00E+00 
2.00E+03 43.3 2.31E-02 5.00E-04 4.86E-04 
4.00E+03 53.9 1.86E-02 2.50E-04 0.00E+00 
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y = 1.89x + 0.279
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Day 4         
Enzyme 2      
KM (µM): 6.93±0.42      
VMAX (µM/23 Hr): 
3.58±0.12    
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
3.37 1.19 0.844 2.97E-01 2.23E-02 
3.74 1.17 0.857 2.67E-01 2.94E-03 
4.12 1.46 0.684 2.43E-01 2.09E-02 
4.49 1.61 0.621 2.23E-01 8.32E-03 
6.00 1.61 0.621 1.67E-01 8.32E-03 
8.83 1.81 0.551 1.13E-01 3.29E-03 
1.20E+01 2.22 0.450 8.33E-02 5.98E-03 
1.40E+01 2.56 0.391 7.14E-02 2.25E-03 
1.80E+01 2.78 0.360 5.56E-02 5.68E-04 
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y = 9.17x + 4.80E-03
R² = 0.972
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Day 5         
Enzyme 1      
KM (µM): 
1.91E03±1.3E02    
  
VMAX (µM/23 Hr): 
208±1.0E01       
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 16.1 6.21E-02 6.67E-03 1.93E-03 
200 19.7 5.08E-02 5.00E-03 8.30E-04 
250 23.8 4.21E-02 4.00E-03 4.11E-04 
300 26.8 3.73E-02 3.33E-03 4.90E-04 
350 29.1 3.44E-02 2.86E-03 5.32E-04 
400 32.4 3.08E-02 2.50E-03 1.58E-04 
450 33.5 2.99E-02 2.22E-03 5.58E-04 
500 50.7 1.97E-02 2.00E-03 2.83E-04 
550 53.0 1.89E-02 1.82E-03 8.62E-05 
1.00E+03 68.1 1.47E-02 1.00E-03 6.72E-05 
2.00E+03 162 6.18E-03 5.00E-04 1.07E-04 
4.00E+03 192 5.22E-03 2.50E-04 7.34E-05 
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y = 0.956x + 0.285
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Day 5         
Enzyme 2      
KM (µM):  
3.35±7.7E-02    
  
VMAX (µM/23 Hr): 
3.51±2.9E-01     
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
2.00 1.28 0.783 5.00E-01 1.66E-02 
2.62 1.83 0.545 3.82E-01 2.49E-02 
2.99 1.56 0.643 3.34E-01 3.56E-03 
3.37 1.67 0.600 2.97E-01 6.18E-03 
3.74 1.72 0.581 2.67E-01 2.25E-03 
4.12 2.00 0.500 2.43E-01 1.59E-03 
4.49 2.11 0.474 2.23E-01 1.10E-02 
6.00 2.11 0.474 1.67E-01 5.40E-03 
8.83 2.22 0.450 1.13E-01 0.00E+00 
1.20E+01 2.67 0.375 8.33E-02 0.00E+00 
1.40E+01 3.00 0.333 7.14E-02 0.00E+00 
1.80E+01 3.56 0.281 5.56E-02 0.00E+00 
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Day 6 
        
Enzyme 1      
KM (µM): 
1.56E03±6.0E01    
  
VMAX (µM/23 Hr): 
159±7.0       
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 14.4 6.92E-02 6.67E-03 1.93E-03 
200 17.9 5.59E-02 5.00E-03 8.30E-04 
250 21.6 4.64E-02 4.00E-03 4.11E-04 
300 24.8 4.03E-02 3.33E-03 4.90E-04 
350 27.5 3.64E-02 2.86E-03 5.32E-04 
400 33.4 2.99E-02 2.50E-03 1.58E-04 
450 35.1 2.85E-02 2.22E-03 5.58E-04 
500 38.0 2.63E-02 2.00E-03 2.83E-04 
550 41.3 2.42E-02 1.82E-03 8.62E-05 
1.00E+03 58.4 1.71E-02 1.00E-03 6.72E-05 
2.00E+03 105 9.51E-03 5.00E-04 1.07E-04 
4.00E+03 143 6.98E-03 2.50E-04 7.34E-05 
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y = 3.64x + 0.354
R² = 0.880
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r)
1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Stationary Phase Supernatant Enzyme Kinetics (Enzyme 2, 
Day 6)
Enzyme 2
Linear (Enzyme 2)
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Day 6         
Enzyme 2      
KM (µM): 10.3±8.1E01      
VMAX (µM/23 Hr): 
2.82±1.9E-01     
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
1/(µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM)/23 Hr 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
1/(µM/23 Hr) 
6.00 1.06 0.947 1.67E-01 1.61E-02 
8.83 1.33 0.750 1.13E-01 0.00E+00 
12.0 1.39 0.720 8.33E-02 0.00E+00 
14.0 1.50 0.667 7.14E-02 0.00E+00 
18.0 2.11 0.474 5.56E-02 0.00E+00 
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y = 5.72x + 5.20E-03
R² = 0.996
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1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Senescence Phase Supernatant Enzyme Kinetics (Enzyme 1, 
Day 7)
Enzyme 1
Linear (Enzyme 1)
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Day 7         
Enzyme 1      
KM (µM): 
1.10E03±3.0E01    
  
VMAX (µM/23 Hr): 
192±9.0       
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 23.7 4.23E-02 6.67E-03 4.36E-04 
200 29.3 3.41E-02 5.00E-03 1.79E-04 
250 34.4 2.90E-02 4.00E-03 2.45E-04 
300 40.0 2.50E-02 3.33E-03 4.89E-05 
350 46.0 2.17E-02 2.86E-03 2.50E-04 
400 53.3 1.88E-02 2.50E-03 2.70E-04 
450 55.6 1.80E-02 2.22E-03 2.53E-04 
500 59.4 1.68E-02 2.00E-03 1.13E-04 
550 64.3 1.56E-02 1.82E-03 1.07E-04 
1.00E+03 85.8 1.17E-02 1.00E-03 1.65E-04 
2.00E+03 134 7.44E-03 5.00E-04 2.90E-04 
4.00E+03 168 5.95E-03 2.50E-04 4.50E-05 
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y = 2.26x + 6.18E-02
R² = 0.950
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1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Senescence Phase Supernatant Enzyme Kinetics (Enzyme 2, 
Day 7)
Enzyme 2
Linear (Enzyme 2)
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Day 7         
Enzyme 2      
KM (µM): 36.6±1.8      
VMAX (µM/23 Hr): 
16.2±7.0E-01     
  
[para-nitrophenylphosphate] (µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
2.00 0.778 1.29 5.00E-01 1.08E-02 
2.62 1.00 1.00 3.82E-01 1.09E-02 
2.99 1.39 0.720 3.34E-01 1.59E-02 
3.37 1.44 0.692 2.97E-01 9.98E-03 
3.74 1.50 0.667 2.67E-01 5.38E-03 
4.12 1.78 0.563 2.43E-01 5.16E-03 
4.49 2.11 0.474 2.23E-01 5.64E-03 
6.00 2.83 0.353 1.67E-01 1.01E-02 
8.83 2.50 0.400 1.13E-01 5.92E-03 
1.20E+01 3.22 0.310 8.33E-02 4.99E-04 
1.40E+01 4.06 0.247 7.14E-02 5.94E-03 
1.80E+01 4.44 0.225 5.56E-02 1.90E-03 
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y = 6.39x + 5.00E-03
R² = 0.991
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1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Senescence Phase Supernatant Enzyme Kinetics (Enzyme 1, 
Day 8)
Enzyme 1
Linear (Enzyme 1)
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Day 8     
Enzyme 1    
 
KM (µM): 
1.28E03±5.0E01    
 
VMAX (µM/23 Hr): 
200±8.0    
 
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 21.8 4.58E-02 6.67E-03 2.61E-02 
200 26.4 3.78E-02 5.00E-03 1.02E-02 
250 31.3 3.19E-02 4.00E-03 1.04E-02 
300 34.9 2.87E-02 3.33E-03 8.04E-03 
350 42.3 2.36E-02 2.86E-03 2.89E-03 
400 50.8 1.97E-02 2.50E-03 1.69E-03 
450 53.3 1.88E-02 2.22E-03 1.09E-03 
500 57.1 1.75E-02 2.00E-03 2.89E-03 
550 60.8 1.64E-02 1.82E-03 3.39E-04 
1.00E+03 82.4 1.21E-02 1.00E-03 2.10E-03 
2.00E+03 123 8.11E-03 5.00E-04 6.53E-04 
4.00E+03 176 5.68E-03 2.50E-04 0.00E+00 
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y = 4.26x + 4.40E-03
R² = 0.963
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1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Senescence Phase Supernatant Enzyme Kinetics (Enzyme 1, 
Day 8 + Glycosidase)
Enzyme 1
Linear (Enzyme 1)
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Day 8 + Glycosidase         
Enzyme 1      
KM (µM): 968±1.3E02      
VMAX (µM/23 Hr): 
227±50       
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
150 32.7 3.06E-02 6.67E-03 9.53E-03 
200 36.8 2.72E-02 5.00E-03 1.26E-02 
250 45.9 2.18E-02 4.00E-03 6.42E-03 
300 52.1 1.92E-02 3.33E-03 1.33E-03 
350 56.2 1.78E-02 2.86E-03 1.39E-03 
400 61.1 1.64E-02 2.50E-03 5.06E-03 
450 66.0 1.52E-02 2.22E-03 3.00E-03 
500 69.9 1.43E-02 2.00E-03 2.69E-03 
550 108 9.28E-03 1.82E-03 1.32E-03 
1.00E+03 147 6.78E-03 1.00E-03 0.00E+00 
2.00E+03 147 6.78E-03 5.00E-04 0.00E+00 
4.00E+03 203 4.93E-03 2.50E-04 0.00E+00 
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y = 2.88x + 8.70E-03
R² = 0.915
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1/[para-nitrophenylphosphate] (1/µM)
Lineweaver-Burk Linear Transformation of the V versus S Curve of the 
L. tarentolae Senescence Phase Supernatant Enzyme Kinetics (Enzyme 2 
Day 8 + Glycosidase)
Enzyme 2
Linear (Enzyme 2)
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Day 8 + Glycosidase         
Enzyme 2      
KM (µM): 331±14      
VMAX (µM/23 Hr): 
115±17     
  
[para-nitrophenylphosphate] 
(µM) 
Average 
1/[para-nitrophenolate] 
(1/µM/23 Hr) 
1/[para-
nitrophenyl 
standard 
deviation 
[para-nitrophenolate] 
(µM/23 Hr) 
phosphate] 
(1/µM) 
[para-
nitrophenol] 
(1/µM/23 Hr) 
2.00 0.278 3.600 5.00E-01 4.99E-04 
2.62 0.778 1.286 3.82E-01 5.44E-04 
2.99 1.28 0.783 3.34E-01 6.06E-04 
3.37 1.22 0.818 2.97E-01 4.42E-04 
3.74 1.22 0.818 2.67E-01 4.25E-04 
4.12 1.33 0.750 2.43E-01 2.90E-05 
4.49 1.72 0.581 2.23E-01 1.75E-04 
6.00 2.00 0.500 1.67E-01 1.37E-04 
8.83 3.11 0.321 1.13E-01 3.07E-04 
12.0 3.50 0.286 8.33E-02 5.76E-05 
14.0 4.39 0.228 7.14E-02 6.42E-05 
18.0 26.5 3.77E-02 5.56E-02 8.58E-05 
 
